CROSS REFERENCE TO RELATED APPLICATION
FIELD
[0002] The present invention relates to a method of forming photochromic segmented multifocal
lenses that involves forming by molding a segmented multifocal lens blank in which
the front surface thereof includes a segmented optical power addition portion, grinding
the rear surface of the lens blank, and forming a photochromic coating layer over
at least a portion of the ground rear surface.
BACKGROUND
[0003] Optical lenses, such as ophthalmic lenses, are often fabricated by molding organic
materials, such as plastics, for reasons including, for example, weight reduction
relative to lenses fabricated from inorganic materials, such as silica glass. For
individuals with presbyopia, ophthalmic lenses can be designed and fabricated to include
more than one lens power within each lens, and are typically referred to as multifocal
lenses. In some instances, the multifocal lens is a segmented multifocal lens in which
the front surface thereof includes at least one segmented optical power addition portion
that extends outward relative to the front surface of the lens.
[0004] Since optical lenses, such as ophthalmic lenses, are sometimes worn under conditions
that involve exposure to actinic radiation, such as sunlight, it is desirable to provide
the lenses with shading. Such shading can be provided by static dyes that do not change
the level of shading and/or color with increased or decreased exposure to actinic
radiation. The static dyes can be provided in the form of a coating over one or more
surfaces of the optical lens. Optical lenses that are provided with shading by static
dyes are generally not well suited for use under low light conditions, such as indoors,
because they provide too much shading under such conditions. Photochromic compounds,
in contrast to static dyes, are capable of reversibly changing the level of shading
and/or color with increased or decreased exposure to actinic radiation.
[0005] In response to certain wavelengths of electromagnetic radiation (or "actinic radiation"),
photochromic compounds, such as indeno-fused naphthopyrans, typically undergo a transformation
from one form or state to another form, with each form having a characteristic or
distinguishable absorption spectrum associated therewith. Typically, upon exposure
to actinic radiation, many photochromic compounds are transformed from a closed-form,
which corresponds to an unactivated (or bleached, e.g., substantially colorless) state
of the photochromic compound, to an open-form, which corresponds to an activated (or
colored) state of the photochromic compound. In the absence of exposure to actinic
radiation, such photochromic compounds are reversibly transformed from the activated
(or colored) state, back to the unactivated (or bleached) state. Compositions and
articles, such as optical lenses, that contain photochromic compounds or have photochromic
compounds applied thereto (e.g., in form of a photochromic coating composition) typically
display colorless (e.g., clear) and colored states that correspond to the colorless
and colored states of the photochromic compounds contained therein or applied thereto.
[0006] With some applications, photochromic compounds are provided in the form of a photochromic
coating on the front surface of an optical lens, since the front surface typically
faces and is directly exposed to the source of actinic radiation, such as sunlight.
Typically, the rear surface of an optical lens blank is ground to introduce a desired
optical correction or ophthalmic prescription into the lens. Providing a photochromic
coating on the front surface of the lens blank allows for grinding of the rear surface
without damaging the photochromic coating.
[0007] With segmented multifocal lens in which the front surface thereof includes at least
one segmented optical power addition portion that extends outward relative to the
front surface of the lens, applying a photochromic coating to the front surface results,
in some instances, in the formation of defects due to a lack of uniform coating thickness
associated with the optical power addition portion. Such a lack of uniform coating
thickness can result in the undesirable formation of line defects including, for example,
darker lines and/or lighter lines, when the coated optical lens is exposed to actinic
radiation. Ophthalmic articles with such coating defects typically do not meet minimal
required cosmetic standards.
WO-A-95/15845 discloses a method of making photochromic segmented multifocal lenses.
[0008] It would be desirable to develop new methods of forming photochromic segmented multifocal
lenses. It would also be desirable that such newly developed methods minimize or eliminate
defects associated with non-uniform coating thicknesses on and around the multifocal
segment where such defects can lead to unacceptable optical distortions.
SUMMARY
[0009] In accordance with the present invention, there is provided a method of forming a
photochromic segmented multifocal lens comprising: (a) forming a segmented multifocal
lens blank by molding, wherein the segmented multifocal lens blank has a front surface
and a rear surface, the front surface of the segmented multifocal lens blank comprising
a segmented optical power addition portion; (b) grinding the rear surface of the segmented
multifocal lens blank, thereby forming a segmented multifocal finished lens having
a front surface and a rear surface, in which the front surface of the segmented multifocal
finished lens comprises the segmented optical power addition portion; and (c) forming
a photochromic coating layer over at least a portion of the rear surface of the segmented
multifocal finished lens, in which the photochromic coating layer comprises at least
one photochromic compound.
[0010] The features that characterize the present invention are pointed out with particularity
in the claims, which are annexed to and form a part of this disclosure. These and
other features of the invention, its operating advantages and the specific objects
obtained by its use will be more fully understood from the following detailed description
in which non-limiting embodiments of the invention are illustrated and described.
BRIEF DESCRIPTION OF THE DRAWINGS
[0011]
FIG. 1 is a representative sectional view of a segmented multifocal lens blank that
can be used with some embodiments of the method of the present invention;
FIG. 2 is a representative sectional view of a segmented multifocal finished lens
that includes a photochromic coating on the rear surface thereof prepared in accordance
with some embodiments of the present invention; and
FIG. 3 is a representative sectional view of a mold in which a segmented multifocal
lens blank can be made in accordance with some embodiments of the present invention.
[0012] In FIG's 1-3 like characters refer to the same structural features and/or components,
as the case may be, unless otherwise stated.
DETAILED DESCRIPTION
[0013] As used herein, the articles "a," "an," and "the" include plural referents unless
otherwise expressly and unequivocally limited to one referent.
[0014] Unless otherwise indicated, all ranges or ratios disclosed herein are to be understood
to encompass any and all subranges or subratios subsumed therein. For example, a stated
range or ratio of "1 to 10" should be considered to include any and all subranges
between (and inclusive of) the minimum value of 1 and the maximum value of 10; that
is, all subranges or subratios beginning with a minimum value of 1 or more and ending
with a maximum value of 10 or less, such as but not limited to, 1 to 6.1, 3.5 to 7.8,
and 5.5 to 10.
[0015] As used herein, unless otherwise indicated, left-to-right representations of linking
groups, such as divalent linking groups, are inclusive of other appropriate orientations,
such as, but not limited to, right-to-left orientations. For purposes of non-limiting
illustration, the left-to-right representation of the divalent linking group

or equivalently -C(O)O-, is inclusive of the right-to-left representation thereof,

or equivalently -O(O)C- or -OC(O)-.
[0016] Other than in the operating examples, or where otherwise indicated, all numbers expressing
dimensions, quantities of ingredients, reaction conditions, and so forth used in the
specification and claims are to be understood as modified in all instances by the
term "about."
[0017] As used herein, molecular weight values of polymers, such as weight average molecular
weights (Mw) and number average molecular weights (Mn), are determined by gel permeation
chromatography using appropriate standards, such as polystyrene standards.
[0018] As used herein, polydispersity index (PDI) values represent a ratio of the weight
average molecular weight (Mw) to the number average molecular weight (Mn) of the polymer
(i.e., Mw/Mn).
[0019] As used herein, the term "polymer" means homopolymers (e.g., prepared from a single
monomer species), copolymers (e.g., prepared from at least two monomer species), and
graft polymers.
[0020] As used herein, the term "(meth)acrylate" and similar terms, such as "(meth)acrylic
acid ester" means methacrylates and/or acrylates. As used herein, the term "(meth)acrylic
acid" means methacrylic acid and/or acrylic acid.
[0021] As used herein, spatial or directional terms, such as "left", "right", "inner", "outer",
"above", "below", and the like, relate to the invention as it is depicted in the drawing
figures. It is to be understood, however, that the invention can assume various alternative
orientations and, accordingly, such terms are not to be considered as limiting.
[0022] All documents, such as but not limited to issued patents and patent applications,
referred to herein, and unless otherwise indicated, are to be considered to be "incorporated
by reference" in their entirety.
[0023] As used herein, recitations of "linear or branched" groups, such as linear or branched
alkyl, are herein understood to include: a methylene group or a methyl group; groups
that are linear, such as linear C
2-C
20 alkyl groups; and groups that are appropriately branched, such as branched C
3-C
20 alkyl groups.
[0024] As used herein, recitations of "optionally substituted" group, means a group, including
but not limited to, alkyl group, cycloalkyl group, heterocycloalkyl group, aryl group,
and/or heteroaryl group, in which at least one hydrogen thereof has been optionally
replaced or substituted with a group that is other than hydrogen, such as, but not
limited to, halo groups (e.g., F, Cl, I, and Br), hydroxyl groups, ether groups, thiol
groups, thio ether groups, carboxylic acid groups, carboxylic acid ester groups, phosphoric
acid groups, phosphoric acid ester groups, sulfonic acid groups, sulfonic acid ester
groups, nitro groups, cyano groups, hydrocarbyl groups (including, but not limited
to: alkyl; alkenyl; alkynyl; cycloalkyl, including poly-fused-ring cycloalkyl and
polycyclocalkyl; heterocycloalkyl; aryl, including hydroxyl substituted aryl, such
as phenol, and including poly-fused-ring aryl; heteroaryl, including poly-fused-ring
heteroaryl; and aralkyl groups), and amine groups, such as -N(R
11')(R
12') where R
11' and R
12' are each independently selected, with some embodiments, from hydrogen, linear or
branched C
1-C
20 alkyl, C
3-C
12 cycloakyl, C
3-C
12 heterocycloalkyl, aryl, and heteroaryl.
[0025] As used herein, recitations of "halo substituted" and related terms (such as, but
not limited to, haloalkyl groups, haloalkenyl groups, haloalkynyl groups, haloaryl
groups and halo-heteroaryl groups) means a group in which at least one, and up to
and including all of the available hydrogen groups thereof is substituted with a halo
group. The term "halo-substituted" is inclusive of "perhalo-substituted." As used
herein, the term perhalo-substituted group and related terms (such as, but not limited
to perhaloalkyl groups, perhaloalkenyl groups, perhaloalkynyl groups, perhaloaryl
groups and perhalo-heteroaryl groups) means a group in which all of the available
hydrogen groups thereof are substituted with a halo group. For example, perhalomethyl
is -CX
3; perhalophenyl is -C
6X
5, where X represents one or more halo groups, such as, but not limited to F.
[0026] The photochromic compounds of the method of the present invention include groups
and sub-groups that can in each case be independently selected from hydrocarbyl and/or
substituted hydrocarbyl. As used herein the term "hydrocarbyl" and similar terms,
such as "hydrocarbyl substituent," means: linear or branched C
1-C
25 alkyl (e.g., linear or branched C
1-C
10 alkyl); linear or branched C
2-C
25 alkenyl (e.g., linear or branched C
2-C
10 alkenyl); linear or branched C
2-C
25 alkynyl (e.g., linear or branched C
2-C
10 alkynyl); C
3-C
12 cycloalkyl (e.g., C
3-C
10 cycloalkyl, and including polycyclic cylcoalkyl); C
3-C
12 heterocycloalkyl (having at least one hetero atom in the cyclic ring, and including
polycyclic heterocycloalkyl); C
5-C
18 aryl (including polycyclic aryl groups) (e.g., C
5-C
10 aryl); C
5-C
18 heteroaryl (having at least one hetero atom in the aromatic ring, and including polycyclic
heterooaryl groups); and C
6-C
24 aralkyl (e.g., C
6-C
10 aralkyl).
[0027] Representative alkyl groups include but are not limited to methyl, ethyl, propyl,
isopropyl, butyl, isobutyl, sec-butyl, tert-butyl, pentyl, neopentyl, hexyl, heptyl,
octyl, nonyl and decyl. Representative alkenyl groups include but are not limited
to vinyl, allyl and propenyl. Representative alkynyl groups include but are not limited
to ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, and 2-butynyl. Representative cycloalkyl
groups include but are not limited to cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl,
and cyclooctyl substituents. Representative heterocycloalkyl groups include but are
not limited to imidazolyl, tetrahydrofuranyl, tetrahydropyranyl and piperidinyl. Representative
aryl groups include but are not limited to phenyl, naphthyl, anthracynyl and triptycenyl.
Representative heteroaryl groups include but are not limited to furanyl, pyranyl,
pyridinyl, isoquinoline, and pyrimidinyl. Representative aralkyl groups include but
are not limited to benzyl, and phenethyl.
[0028] The term "substituted hydrocarbyl" as used herein means a hydrocarbyl group in which
at least one hydrogen thereof has been substituted with a group that is other than
hydrogen, such as, but not limited to, halo groups, hydroxyl groups, ether groups,
thiol groups, thio ether groups, carboxylic acid groups, carboxylic acid ester groups,
phosphoric acid groups, phosphoric acid ester groups, sulfonic acid groups, sulfonic
acid ester groups, nitro groups, cyano groups, hydrocarbyl groups (e.g., alkyl, alkenyl,
alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, and aralkyl groups), and
amine groups, such as -N(R
11')(R
12') where R
11' and R
12' are each independently selected from hydrogen, hydrocarbyl and substituted hydrocarbyl.
[0029] The term "substituted hydrocarbyl" is inclusive of halohydrocarbyl (or halo substituted
hydrocarbyl) substituents. The term "halohydrocarbyl" as used herein, and similar
terms, such as halo substituted hydrocarbyl, means that at least one hydrogen atom
of the hydrocarbyl (e.g., of the alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl,
aryl, heteroaryl, and aralkyl groups) is replaced with a halogen atom selected from
chlorine, bromine, fluorine and iodine. The degree of halogenation can range from
at least one hydrogen atom but less than all hydrogen atoms being replaced by a halogen
atom (e.g., a fluoromethyl group), to full halogenation (perhalogenation) in which
all replaceable hydrogen atoms on the hydrocarbyl group have each been replaced by
a halogen atom (e.g., trifluoromethyl or perfluoromethyl). Correspondingly, the term
"perhalohydrocarbyl group" as used herein means a hydrocarbyl group in which all replaceable
hydrogens have been replaced with a halogen. Examples of perhalohydrocarbyl groups
include, but are not limited to, perhalogenated phenyl groups and perhalogenated alkyl
groups.
[0030] The hydrocarbyl and substituted hydrocarbyl groups from which the various groups
described herein can each be independently selected, in some instances and with some
embodiments, can in each case be independently and optionally interrupted with at
least one of -O-, -S-, -C(O)-, -C(O)O-, -S(O)-, -SO
2-, -N=N-, -N(R
11')- where R
11' is selected from hydrogen, hydrocarbyl or substituted hydrocarbyl, -Si(OR
8')
w(R
8')
t-, where w and t are each independently selected from 0 to 2, provided that the sum
of w and t is 2, and each R
8' is independently selected from hydrogen, hydrocarbyl and substituted hydrocarbyl,
and combinations of two or more thereof. As used herein, by interrupted with at least
one of -O-, -S-, -C(O)-, -C(O)O-, -OC(O)O-, -S(O)-, -SO
2-, -N=N-, -N(R
11')-, and -Si(OR
8)
w(R
8)t-, means that at least one carbon of, but less than all of the carbons of, the hydrocarbyl
group or substituted hydrocarbyl group, is in each case independently replaced with
one of the recited divalent non-carbon linking groups. The hydrocarbyl and substituted
hydrocarbyl groups can be interrupted with two or more of the above recited linking
groups, which can be adjacent to each other or separated by one or more carbons. For
purposes of non-limiting illustration, a combination of adjacent -C(O)- and-N(R
11')- can provide a divalent amide linking or interrupting group, -C(O)-N(R
11')-. For purposes of further non-limiting illustration, a combination of adjacent
-N(R
11')-,-C(O)- and -O- can provide a divalent carbamate (or urethane) linking or interrupting
group, -N(R
11')-C(O)-O-, where R
11' is hydrogen.
[0031] The term "alkyl" as used herein, in accordance with some embodiments, means linear
or branched alkyl, such as but not limited to, linear or branched C
1-C
25 alkyl, or linear or branched C
1-C
10 alkyl, or linear or branched C
2-C
10 alkyl. Examples of alkyl groups from which the various alkyl groups of the present
invention can be selected from, include, but are not limited to, those recited previously
herein. Alkyl groups of the various compounds of the present invention can, with some
embodiments, include one or more unsaturated linkages selected from -CH=CH- groups
and/or one or more -C=C- groups, provided the alkyl group is free of two or more conjugated
unsaturated linkages. With some embodiments, the alkyl groups are free of unsaturated
linkages, such as -CH=CH- groups and -C=C-groups.
[0032] The term "cycloalkyl" as used herein, in accordance with some embodiments, means
groups that are appropriately cyclic, such as but not limited to, C
3-C
12 cycloalkyl (including, but not limited to, cyclic C
5-C
7 alkyl) groups. Examples of cycloalkyl groups include, but are not limited to, those
recited previously herein. The term "cycloalkyl" as used herein in accordance with
some embodiments also includes: bridged ring polycycloalkyl groups (or bridged ring
polycyclic alkyl groups), such as but not limited to, bicyclo[2.2.1]heptyl (or norbornyl)
and bicyclo[2.2.2]octyl; and fused ring polycycloalkyl groups (or fused ring polycyclic
alkyl groups), such as, but not limited to, octahydro-1H-indenyl, and decahydronaphthalenyl.
[0033] The term "heterocycloalkyl" as used herein, in accordance with some embodiments,
means groups that are appropriately cyclic, such as but not limited to, C
3-C
12 heterocycloalkyl groups or C
5-C
7 heterocycloalkyl groups, and which have at least one hetero atom in the cyclic ring,
such as, but not limited to, O, S, N, P, and combinations thereof. Examples of heterocycloalkyl
groups include, but are not limited to, those recited previously herein. The term
"heterocycloalkyl" as used herein, in accordance with some embodiments, also includes:
bridged ring polycyclic heterocycloalkyl groups, such as but not limited to, 7-oxabicyclo[2.2.1]heptanyl;
and fused ring polycyclic heterocycloalkyl groups, such as but not limited to, octahydrocyclopenta[b]pyranyl,
and octahydro-1H-isochromenyl.
[0034] The term "heteroaryl," as used herein, in accordance with some embodiments, includes
but is not limited to C
5-C
18 heteroaryl, such as but not limited to C
5-C
10 heteroaryl (including fused ring polycyclic heteroaryl groups) and means an aryl
group having at least one hetero atom in the aromatic ring, or in at least one aromatic
ring in the case of a fused ring polycyclic heteroaryl group. Examples of heteroaryl
groups include, but are not limited to, those recited previously herein.
[0035] As used herein, the term "fused ring polycyclic-aryl-alkyl group" and similar terms
such as, fused ring polycyclic-alkyl-aryl group, fused ring polycyclo-aryl-alkyl group,
and fused ring polycyclo-alkyl-aryl group means a fused ring polycyclic group that
includes at least one aryl ring and at least one cycloalkyl ring that are fused together
to form a fused ring structure. For purposes of non-limiting illustration, examples
of fused ring polycyclic-aryl-alkyl groups include, but are not limited to indenyl,
9H-flourenyl, cyclopentanaphthenyl, and indacenyl.
[0036] The term "aralkyl," as used herein, and in accordance with some embodiments, includes
but is not limited to C
6-C
24 aralkyl, such as but not limited to C
6-C
10 aralkyl, and means an aryl group substituted with an alkyl group. Examples of aralkyl
groups include, but are not limited to, those recited previously herein.
[0037] The method of the present invention involves with some embodiments, forming a segmented
multifocal lens blank having a front surface and a rear surface, in which the front
surface of the segmented multifocal lens blank includes a segmented optical power
addition portion. For purposes of non-limiting illustration and with reference to
FIG. 1 of the drawings, there is depicted a segmented multifocal lens blank 11 that
includes a front surface 14 and a rear surface 17. Front surface 14 of segmented multifocal
lens blank 11 includes a segmented optical power addition portion 20. Segmented optical
power addition portion 20 extends outward relative to front surface 14. As depicted
in FIG. 1, segmented optical power addition portion 20 represents or defines a bifocal
portion of segmented multifocal lens blank 11. With some embodiments, the segmented
optical power addition portion of the segmented lens blank can include a plurality
of segments, not depicted, and can define, for example, a trifocal portion of the
segmented multifocal lens blank.
[0038] The segmented multifocal lens blank can have any suitable size and geometric shape.
With some embodiments, the segmented multifocal lens blank is substantially circular,
having a diameter of from 65 mm to 85 mm, and a thickness of from 5 mm to 20 mm.
[0039] With some embodiments, the segmented optical power addition portion includes an upper
portion and a lower portion. With reference to FIG. 1, segmented optical power addition
portion 20 has an upper portion 23 and a lower portion 26, which can each independently
have any suitable shape. Upper portion 23 is, with some embodiments and as depicted,
in the form of a ledge that extends laterally outward from front surface 14. With
some further embodiments, upper portion 23 has an arcuate shape, not depicted, that
extends gradually and arcuately outward from front surface 14. Lower portion 26, with
some embodiments can extend outward from or relative to front surface 14, and have
any suitable shape, such as a ledge (not depicted) or arcuate shape. With some embodiments,
lower portion 26 is substantially continuous with the outer edge 29 of the segmented
multifocal lens blank (not depicted).
[0040] The segmented multifocal lens blank is, with some embodiments, a substantially unitary
article, such as depicted with the segmented multifocal lens blank 11 of FIG. 1. In
accordance with some further embodiments, the segmented multifocal lens blank is composed
of two or more portions or layers (not depicted in the drawings). With some embodiments,
the segmented multifocal lens blank includes at least two layers, in which each layer
is independently selected (or formed) from, a lens molding composition (or lens composition),
a mold insert layer, and an in-mold coating composition, provided that at least one
layer is (or is formed from) a lens molding composition. The lens molding composition
is, with some embodiments, chosen from a thermoplastic lens molding composition, a
crosslinkable (or curable) lens molding composition, and combinations thereof, as
discussed in further detail herein.
[0041] In further accordance with some embodiments of the present invention, the rear surface
of the segmented multifocal lens blank is subjected to grinding, which results in
formation of a segmented multifocal finished lens having a front surface and a rear
surface. The front surface of the segmented multifocal finished lens includes the
segmented optical power addition portion. Grinding of the rear surface of the segmented
multifocal lens blank is conducted, with some embodiments, for purposes of: (i) imparting
an optical correction or ophthalmic prescription into the segmented multifocal lens
blank (and correspondingly the resulting segmented multifocal finished lens); and/or
(ii) thinning / reducing the thickness of the segmented multifocal lens blank (and
correspondingly the resulting segmented multifocal finished lens). Grinding of the
rear surface is, with some embodiments, conducted in accordance with art-recognized
methods. Grinding, with some embodiments, includes rotating and/or reciprocating a
grinding pad over at least a portion of the rear surface with a liquid grinding composition
there-between, which optionally includes a grinding media.
[0042] The method of the present invention, with some embodiments, further includes forming
a photochromic coating layer over at least a portion of the rear surface of the segmented
multifocal finished lens. The photochromic coating layer includes at least one photochromic
compound, as will be described in further detail herein.
[0043] For purposes of nonlimiting illustration, and with reference to FIG. 1 and FIG. 2
of the drawings, rear surface 17 of segmented multifocal lens blank 11 is subjected
to grinding, which results in the formation of segmented multifocal finished lens
32. Segmented multifocal finished lens 32 has a front surface 14 and a rear surface
35. Front surface 14 of segmented multifocal finished lens 32 includes the segmented
optical power addition portion 20. In accordance with some embodiments of the present
invention, a photochromic coating layer 38 is formed over at least a portion of rear
surface 35 of segmented multifocal finished lens 32. With some embodiments, photochromic
coating layer 38 is formed over substantially all of rear surface 35.
[0044] Formation of the photochromic coating layer over at least a portion of the rear surface
of the segmented multifocal finished lens results, with some embodiments, in the formation
of the photochromic segmented multifocal lens. In accordance with some further embodiments,
the method of the present invention further includes edging the photochromic segmented
multifocal finished lens, which results in formation of a photochromic segmented multifocal
edged lens that is dimensioned to be received and retained within an optical frame,
such as, but not limited to, an ophthalmic frame. Edging, with some embodiments, is
conducted in accordance with art-recognized methods.
[0045] With reference to FIG. 2 and for purposes of non-limiting illustration, the formation
of photochromic coating layer 38 on at least a portion of rear surface 35 of segmented
multifocal finished lens 32 results, with some embodiments, in the formation of photochromic
segmented multifocal finished lens 4. Photochromic segmented multifocal finished lens
4 includes segmented multifocal finished lens 32 (or segmented multifocal finished
lens body 32), which includes a front surface 14, a rear surface 35 and outer edge
29 (which is, with some embodiments, a substantially continuous outer edge 29). Front
surface 14 includes a segmented optical power addition portion 20, as described previously
herein. Photochromic segmented multifocal finished lens 4 further includes photochromic
coating layer 38, which resides over at least a portion of rear surface 35.
[0046] Photochromic segmented multifocal finished lens 4 is, in accordance with some embodiments,
subjected to edging, which results in formation of a photochromic segmented multifocal
edged lens (not shown in the drawings). Edging, with some embodiments, is conducted
in accordance with art-recognized methods that involve trimming or cutting outer edge
29 so that the resulting photochromic segmented multifocal edged lens is dimensioned
and has a shape for receipt and retention within an optical frame (or ophthalmic lens
frame). The photochromic segmented multifocal edged lens can, with some embodiments,
have a shape (relative to a top plan view thereof - not shown) chosen from, for example,
circular shapes, elliptical shapes, and polygonal shapes, such as triangular shapes,
rectangular shapes, hexagonal shapes, and octagonal shapes, and combinations thereof.
[0047] The photochromic coating layer can have any suitable thickness, provided it provides
a desirable level of photochromic properties, such as but not limited to a desirable
range of optical density values. With some embodiments, the photochromic coating layer
has a thickness of from 0.5 to 50 microns, such as from 1 to 45 microns, or from 2
to 40 microns, or from 5 to 30 microns, or from 10 to 25 microns.
[0048] Forming the segmented multifocal lens blank by molding includes, with some embodiments
of the present invention; (i) providing a mold having an interior space; (ii) introducing
a lens molding composition into the interior space of the mold; and (iii) removing
the segmented multifocal lens blank from the mold. The lens molding composition is,
with some embodiments, chosen from a thermoplastic lens molding composition, a crosslinkable
(or curable) lens molding composition, and combinations thereof.
[0049] For purposes of non-limiting illustration and with reference to FIG. 3 of the drawings,
mold 5 includes a first mold portion 41 having an interior surface 44, and a second
mold portion 47 having an interior surface 50. When first mold portion 41 and second
mold portion 47 are brought into abutting relationship with each other, such as along
abutment line 53, interior surface 44 and interior surface 50 together define interior
space 56 of mold 5. Mold 5 can, with some embodiments, include additional mold portions
(not shown). The mold portions, such as first and second mold portions 41 and 47 can
be fabricated from any suitable material, such as, with some embodiments, metal, ceramic,
silica glass, borosilicate glass, quartz glass, and combinations thereof. Mold 5 can,
with some embodiments, include one or more gaskets (not shown) that serve to seal
interior space 56.
[0050] The lens molding composition is introduced into the interior space of the mold, with
some embodiments, through one or more channels. With further reference to FIG. 3,
first mold portion 41 of mold 5 includes a channel 59 that provides fluid communication
between an inlet 62 of channel 59 and interior space 56 of mold 5. The lens molding
composition, with some embodiments, is introduced from a reservoir (not shown) into
interior space 56 through inlet 62 and channel 59. Interior space 56 is substantially
filled with the lens molding composition. The lens molding composition within interior
space 56 is: (i) subjected to crosslinking conditions; and/or (ii) allowed to cool
to a temperature that allows for removal of the resulting segmented multifocal lens
blank from mold 5, and in particular from interior space 56 thereof.
[0051] Removing the segmented multifocal lens blank from the mold involves, with some embodiments,
separating the mold portions from each other. With some embodiments, after formation
of the segmented multifocal lens blank within interior space 56 of mold 5, the first
41 and second 47 mold portions are separated from each other, and the segmented multifocal
lens blank (e.g., 11) is in effect removed from interior space 56.
[0052] The segmented multifocal lens blank includes an organic matrix. The organic matrix
of the segmented multifocal lens blank includes, with some embodiments, one or more
art-recognized oligomeric and/or polymeric organic materials from which optical lenses,
such as ophthalmic lenses, are fabricated. In accordance with some embodiments, the
segmented multifocal lens blank includes an organic matrix that includes, polycarbonate,
poly(allyl-carbonate), polyurethane, polythiourethane, poly(urea-urethane), poly(meth)acrylate,
polyolefin, polyvinyl, polyester, polyether, poly(siloxane), and combinations thereof.
Additional and/or more specific examples of polymers that can be included in the organic
matrix of the segmented multifocal lens blank include, but are not limited to: LEXAN
thermoplastic polycarbonate; MYLAR polyester; PLEXIGLASS poly(methyl methacrylate);
and TRIVEX poly(urea-urethane).
[0053] The lens molding composition is, with some embodiments, chosen from a thermoplastic
lens molding composition, a crosslinkable lens molding composition, and combinations
thereof. Crosslinkable molding compositions are crosslinked to form a 3-dimensional
crosslink network of covalent bonds. Crosslinking of the crosslinkable molding composition
can be achieved by methods including, but not limited to, exposure to elevated temperature,
exposure to actinic light, allowing mixed reactive components to react with each other,
and combinations thereof.
[0054] The lens molding composition, with some embodiments, includes one or more radically
polymerizable monomers. Examples of radically polymerizable monomers that can be included
in the lens molding composition include, but are not limited to: C
1-C
20 linear, branched, or cyclic alkyl (meth)acrylate monomers; allylic monomers; bis(allyl
carbonate) monomers, such as polyol(allyl carbonate) monomers, such as polyalkylene
glycol bis(allyl carbonate) monomers, dithylene glycol bis(allyl carbonate) monomer,
bisphenol A bis(allyl carbonate) monomer, and alkoxylated bisphenol A bis(allyl carbonate)
monomers; polyfunctional (meth)acrylate monomers, such as alkylene glycol bis(meth)acrylate
monomers, polyalkylene glycol bis(meth)acrylate monomers, trimethylolpropane tris(meth)acrylate
monomer, alkoxylated trimethylolpropane tris(meth)acrylate monomers, polyalkoxylated
trimethylolpropane tris(meth)acrylate monomers, pentaerythritol tris(meth)acrylate,
pentaerythritol tetrakis(meth)acrylate, alkoxylated pentaerythritol tris(meth)acrylate,
alkoxylated pentaerythritol tetrakis(meth)acrylate, polyalkoxylated pentaerythritol
tris(meth)acrylate, polyalkoxylated pentaerythritol tetrakis(meth)acrylate, dipentaerythritol
hexakis(meth)acrylate, alkoxylated, dipentaerythritol hexakis(meth)acrylate, and polyalkoxylated
dipentaerythritol hexakis(meth)acrylate; vinyl aromatic monomers, such as styrene,
alpha-methylstyrene, p-chloromethylstyrene, divinyl benzene, vinyl naphthalene and
divinyl naphthalene; vinyl esters of carboxylic acids such as, vinyl acetate, vinyl
butyrate, vinyl 3,4-dimethoxybenzoate, and vinyl benzoate; olefin monomers, such as
propylene, 1-butene, 1,3-butadiene, isobutylene and diisobutylene; and other ethylenically
unsaturated radically polymerizable monomers, such as cyclic anhydrides (such as maleic
anhydride, 1-cyclopentene-1,2-dicarboxylic anhydride and itaconic anhydride), esters
of acids that are unsaturated but do not have alpha, beta-ethylenic unsaturation,
(such as methyl ester of undecylenic acid), and diesters of ethylenically unsaturated
dibasic acids (such as diethyl maleate).
[0055] As used herein, by "allylic monomer(s)" is meant monomers containing substituted
and/or unsubstituted allylic functionality, such as one or more radicals represented
by the following Formula (A),
H
2C=C(R
d)-CH
2- (A)
[0056] With reference to Formula (A), R
d is hydrogen, halogen or a C
1 to C
4 alkyl group. With some embodiments, R
d is hydrogen or methyl and consequently Formula (A) represents an unsubstituted (meth)allyl
radical. Examples of allylic monomers include, but are not limited to: (meth)allyl
alcohol; (meth)allyl ethers, such as methyl (meth)allyl ether; allyl esters of carboxylic
acids, such as (meth)allyl acetate, (meth)allyl butyrate, (meth)allyl 3,4-dimethoxybenzoate
and (meth)allyl benzoate.
[0057] Examples of C
1-C
20 linear, branched, or cyclic alkyl (meth)acrylate monomers that can be present in
the lens molding composition include, but are not limited to, methyl (meth)acrylate,
ethyl (meth)acrylate, propyl (meth)acrylate, isopropyl (meth)acrylate, butyl (meth)acrylate,
isobutyl (meth)acrylate, tert-butyl (meth)acrylate, 2-ethylhexyl (meth)acrylate, lauryl
(meth)acrylate, isobornyl (meth)acrylate, cyclohexyl (meth)acrylate and 3,3,5-trimethylcyclohexyl
(meth)acrylate.
[0058] The lens molding composition can further include, with some embodiments, an initiator
that is capable of initiating free radical polymerization of and amongst the ethylenically
unsaturated groups of the monomers thereof. With some embodiments, the lens molding
composition includes a free radical initiator that is thermally activated. By "thermally
activated" means the free radical initiator become active at elevated temperature,
such as at temperatures greater than ambient room temperature, such as greater than
25°C, as will be described in further detail herein.
[0059] The thermally activated free radical initiator can, with some embodiments, be selected
from organic peroxy compounds, azobis(organonitrile) compounds, N-acyloxyamine compounds,
O-imino-isourea compounds, and combinations of two or more thereof.
[0060] Examples of organic peroxy compounds, that can be used as thermal polymerization
initiators include, but are not limited to: peroxymonocarbonate esters, such as tertiarybutylperoxy
2-ethylhexyl carbonate and tertiarybutylperoxy isopropyl carbonate; peroxyketals,
such as 1,1-di-(t-butyl peroxy)-3,3,5-trimethylcyclohexane; peroxydicarbonate esters,
such as di(2-ethylhexyl) peroxydicarbonate, di(secondary butyl) peroxydicarbonate
and diisopropylperoxydicarbonate; diacyperoxides, such as 2,4-dichlorobenzoyl peroxide,
isobutyryl peroxide, decanoyl peroxide, lauryl peroxide, propionyl peroxide, acetyl
peroxide, benzoyl peroxide, p-chlorobenzoyl peroxide; peroxyesters such as t-butylperoxy
pivalate, t-butylperoxy octylate, and t-butylperoxyisobutyrate; methylethylketone
peroxide, and acetylcyclohexane sulfonyl peroxide. With some embodiments, further
examples of peroxy compounds from which the free radical initiator can be selected
include, but are not limited to, 2,5-dimethyl-2,5-di(2-ethylhexylperoxy)hexane, and/or
1,1-bis(tert-butylperoxy)-3,3,5-trimethylcyclohexane.
[0061] Examples of azobis(organonitrile) compounds, that can be used as thermal polymerization
initiators in the lens molding composition, include, but are not limited to, azobis(isobutyronitrile),
2,2'-azobis(2-methyl-butanenitrile), and/or azobis(2,4-dimethylvaleronitrile).
[0062] With some further embodiments, the thermally activated free radical initiator is
selected from 1-acetoxy-2,2,6,6-tetramethylpiperidine, and/or 1,3-dicyclohexyl-O-(N-cyclohexylideneamino)-isourea.
[0063] The lens molding composition, with some embodiments, includes a first reactant that
has active hydrogen groups, and a second reactant that has groups that are reactive
with (and form covalent bonds) with the active hydrogen groups of the first reactant,
such as but not limited to, oxirane groups, thiooxirane groups, isocyanate groups,
thioisocyanate groups, cyclic carbonate groups, and cyclic ester groups. With some
embodiments, the lens molding composition includes: a first reactant having active
hydrogen groups selected from hydroxyl, thiol, primary amine, and secondary amine;
and a second reactant having isocyanate groups.
[0064] Examples of isocyanate functional reactants that can be included in the lens molding
composition include, but are not limited to, toluene-2,4-diisocyanate; toluene-2,6-diisocyanate;
diphenyl methane-4,4'-diisocyanate; diphenyl methane-2,4'-diisocyanate; para-phenylene
diisocyanate; biphenyl diisocyanate; 3,3'-dimethyl-4,4'-diphenylene diisocyanate;
tetramethylene-1,4-diisocyanate; hexamethylene-1,6-diisocyanate; 2,2,4-trimethyl hexane-1,6-diisocyanate;
lysine methyl ester diisocyanate; bis(isocyanato ethyl)fumarate; isophorone diisocyanate;
ethylene diisocyanate; dodecane-1,12-diisocyanate; cyclobutane-1,3-diisocyanate; cyclohexane-1,3-diisocyanate;
cyclohexane-1,4-diisocyanate; methyl cyclohexyl diisocyanate; hexahydrotoluene-2,4-diisocyanate;
hexahydrotoluene-2,6-diisocyanate; hexahydrophenylene-1,3-diisocyanate; hexahydrophenylene-1,4-diisocyanate;
perhydrodiphenylmethane-2,4'-diisocyanate; perhydrodiphenylmethane-4,4'-diisocyanate
and mixtures thereof.
[0065] Examples of polyols that can be included in the lens molding composition include,
but are not limited to, glycerin, trimethylolpropane, trimethylolethane, trishydroxyethylisocyanurate,
pentaerythritol, ethylene glycol, propylene glycol, trimethylene glycol, 1,3-, 1,2-
and 1,4-butanediols, heptanediol, hexanediol, octanediol, 2,2-bis(4-cyclohexanol)propane,
neopentyl glycol, 2,2,3-trimethylpentane-1,3-diol, 1,4-dimethylolcyclohexane, 2,2,4-trimethylpentane
diol, and like polyols.
[0066] Examples of polythiols that can be included in the lens molding composition include,
but are not limited to, art-recognized polythiols. With some embodiments, a hydroxy
functional material, such as one or more polyols as described previously herein, is
reacted with epithiochlorohydrin, which results in the formation of an intermediate
material having at least two thiirane groups. The thiirane groups of the intermediate
material can, with some embodiments, be subsequently ring-opened in accordance with
art-recognized methods so as to form a material having at least two thiol groups,
which can be included in the lens molding composition.
[0067] Classes of polyamines that can be included in the lens molding composition, with
some embodiments, include but are not limited to linear or branched aliphatic amines,
cycloaliphatic amines, heterocycloaliphatic amines, aromatic amines, heteroaromatic
amines, and combinations of two or more thereof. In accordance with some further embodiments,
examples of polyamines that can be included in the lens molding composition include,
but are not limited to, diaminocyclohexane, 4,4'-methylenedi(cyclohexylamine), 4,4'-(propane-2,2-diyl)dicyclohexanamine,
3,3'-dimethyl-methylenedi(cyclohexylamine), 4,4'-(propane-2,2-diyl)dianiline, 4,4'-methylenedianiline,
piperazine, N-amino ethyl piperazine, 5-amino-1-aminomethyl-1,3,3-trimethyl-cyclohexane,
diamino ethane, diamino propane, diaminobutane, diaminopentane, diaminohexane, diaminoheptane,
diaminooctane, diaminodecane, diaminoundecane, diaminododecane, dicyanamide, 4,4'-diaminodiphenyl
sulfone, melamine, and combinations of two or more thereof.
[0068] With some embodiments, the lens molding composition is subjected to elevated temperature
so as to cause and/or expedite crosslinking and cure thereof (in the case of a crosslinkable
lens molding composition). With some embodiments, after introduction into the interior
space of the mold, the lens molding composition is heated, optionally in the presence
of an initiator, from room temperature, such as 25°C, up to 50°C to 150°C, over a
period of from 2 hours to 48 hours, or from 55°C up to 90°C or 100°C over a period
of from 12 to 24 hours, or from 65°C up to 115°C or 125°C over a period of from 12
to 24 hours.
[0069] The segmented multifocal lens blank, with some embodiments, is prepared in accordance
with art-recognized molding methods using art-recognized lens molding compositions,
such as described in
US 4,279,401,
US 4,190,621, and
US 4,836,960.
[0070] The photochromic coating layer includes at least one photochromic compound. With
some embodiments, the photochromic coating layer, includes indeno-fused naphthopyrans,
naphtho[1,2-b]pyrans, naphtho[2,1-b]pyrans, spirofluoroeno[1,2-b]pyrans, phenanthropyrans,
quinolinopyrans, fluoroanthenopyrans, spiropyrans, benzoxazines, naphthoxazines, spiro(indoline)naphthoxazines,
spiro(indoline)pyridobenzoxazines, spiro(indoline)fluoranthenoxazines, spiro(indoline)quinoxazines,
fulgides, fulgimides, diarylethenes, diarylalkylethenes, diarylalkenylethenes, and
combinations of two or more thereof.
[0071] The photochromic compound is present in the photochromic coating layer in an amount
at least sufficient so as to provide the photochromic segmented multifocal lens with
a desirable level of photochromic properties, which in some embodiments is referred
to as a photochromic amount. With some embodiments, the amount of photochromic compound(s)
present in the photochromic coating layer is from 0.01 percent by weight to 40 percent
by weight, based on the total weight of photochromic coating layer.
[0072] The photochromic coating layer is formed on or over the rear surface of the photochromic
segmented multifocal lens, with the method of the present invention. The source of
actinic radiation that activates the photochromic compounds of the photochromic coating
layer is typically located forward of the front surface of the photochromic segmented
multifocal lens. A portion of the electromagnetic radiation of the actinic radiation
source is typically absorbed over a range of wavelengths by and as it passes through
the organic matrix of the photochromic segmented multifocal lens and any optional
further coating layers that are present and positioned forward of the photochromic
layer. As such, with some embodiments, each photochromic compound of the photochromic
coating layer is selected such that it is activated by wavelengths of electromagnetic
radiation that are greater than those that are absorbed by the organic matrix of the
photochromic segmented multifocal lens and any optional further coating layers that
are present and positioned forward of the photochromic layer. By "activated" is meant
the photochromic compound is converted from a closed-form (bleached, e.g., substantially
colorless state) to an open-form (colored state).
[0073] In accordance with some embodiments, the photochromic compound, of the photochromic
coating layer, is converted from a closed-form to an open-form by electromagnetic
radiation having a wavelength of greater than 320 nm, or greater than 340 nm.
[0074] The photochromic compound, of the photochromic coating layer, is converted from a
closed-form to an open-form by electromagnetic radiation having a wavelength of greater
than 390 nm, with some further embodiments.
[0075] In accordance with some additional embodiments, the photochromic compound, of the
photochromic coating layer, is converted from a closed-form to an open-form by electromagnetic
radiation having a wavelength of greater than 390 nm to 450 nm.
[0076] The photochromic compound, of the photochromic coating layer, includes at least one
indeno-fused naphthopyran, in accordance with some embodiments of the present invention.
[0077] In accordance with some embodiments of the present invention, the indeno-fused naphthopyran
of the photochromic coating layer is represented by the following Formula (I),

[0078] With reference to Formula (I), a pi-conjugation extending group is bonded to at least
one of, 6-position, the 7-position, and/or the 11-position of the indeno-fused naphthopyran,
with some embodiments. With further reference to Formula (I), and in accordance with
some further embodiments, a pi-conjugation extending group is bonded to the 11-position
of the indeno-fused naphthopyran, and the 6-position and the 7-position are each free
of a pi-conjugation extending group bonded thereto. The pi-conjugation extending group
in each case independently extends the pi-conjugation system of the indeno-fused naphthopyran.
With further reference to Formula (I), the 13-position of said indeno-fused naphthopyran
is free of spiro-substituents, with some embodiments.
[0079] As used herein, the terms "10-position," "11-position, "12-position, "13-position,"
etc. refer to the 10-, 11-, 12- and 13-position, etc. of the ring atoms of the indeno-fused
naphthopyran, respectively. With some embodiments the indeno-fused naphthopyran is
an indeno[2',3':3,4]naphtho[1,2-b]pyran, and the ring atoms of the indeno-fused naphthopyran
are numbered as shown in Formula (I) above.
[0080] As used herein, the term "pi-conjugation extending group" and similar terms, such
as "pi-conjugation extending group bonded to the 6-position, 7-positions, and/or 11-position
of the indeno-fused naphthopyran" means a group having at least one pi-bond (π-bond)
(e.g., a double bond and/or a triple bond) in conjugation with the pi-conjugated system
of the indeno-fused naphthopyran. In such a system, the pi-electrons in the pi-conjugated
system of the indeno-fused naphthopyran can be de-localized over the combined pi-system
of the indeno-fused naphthopyran and the pi-conjugation extending group bonded to
the 6-position, 7-position, and/or the 11-position thereof (i.e., the group having
at least one pi-bond in conjugation with the pi-conjugated system of the indeno-fused
naphthopyran). Conjugated bond systems can, with some embodiments, be represented
by an arrangement of at least two double or triple bonds separated by one single bond,
that is a system containing alternating double (and/or triple) bonds and single bonds,
wherein the system contains at least two double (and/or triple) bonds. Non-limiting
examples of groups that can extend the pi-conjugated system of the indeno-fused naphthopyran,
with some embodiments, are set forth below in further detail.
[0081] The pi-conjugation extending group that is bonded to the 6-position, 7-position,
and/or the 11-position of the indeno-fused naphthopyran represented by Formula (I),
with some embodiments, in each case independently includes at least one pendent halo-substituted
group bonded thereto.
[0082] As used herein, the term "pendent halo-substituted group" and similar terms, such
as pendent halo-substituted alkyl group, means a group in which at least 50 percent
by number (e.g., at least 60, 65, 80 or 90 percent by number) of available substitutable
atoms (e.g., hydrogen atoms) that may be substituted (i.e., replaced) with a halogen
atom (e.g., fluorine) are so substituted with a halogen atom, based on the total number
of such available substitutable atoms. For purposes of non-limiting illustration,
in the case a pendent halo-substituted methyl group, at least two of the three available
substitutable hydrogen atoms thereof are substituted with a halogen atom, in which
case the pendent halo-substituted methyl group may be selected from dihalomethyl (e.g.,
-CHX
2), trihalomethyl (-CX
3) and combinations thereof, wherein each X independently is the same or a different
halogen atom in each instance. With some embodiments of the present invention, the
pendent halo-substituted group is selected from halo-substituted groups in which 100
percent by number of available substitutable atoms are substituted by a halogen atom,
based on total number of available substitutable atoms. Pendent halo-substituted groups
in which 100 percent by number of available substitutable atoms are substituted by
a halogen atom, based on total number of available substitutable atoms, are inclusive
of and may be referred to herein and in the claims as "pendent perhalo groups" (e.g.,
pendent perhalo alkyl groups).
[0083] The term "pendent halo-substituted group" as used herein, is not inclusive of one
or more single halogens or halo groups (e.g., -F) bonded directly to the pi-conjugation
extending group of the 6-position, the 7-position, and/or the 11-position of the indeno-fused
naphthopyran. While, with some embodiments, the pi-conjugation extending group, of
the 6-position, 7-position, and/or the 11-position of the indeno-fused naphthopyran
of the photochromic material of the present invention, can in each case independently
have one or more single halogens (or halo groups) bonded directly thereto, the term
"pendent halo-substituted group," is not inclusive of such one or more single halogens.
[0084] More particularly, as used herein, the term "pendent halo-substituted group" and
similar terms, such as pendent halo-substituted alkyl group, means a group in which:
(i) at least 50 percent by number of available substitutable atoms are substituted
by a halogen atom, based on total number of available substitutable atoms, as described
above; and (ii) at least one (and more typically each) available substitutable atom
(e.g., hydrogen atom) of the alpha carbon (and more typically of each of the alpha
and beta carbons) of the halo-substituted group is substituted with a halogen atom.
For purposes of non-limiting illustration, when the pendent halo-substituted group
is halo-substituted ethyl, the halo-substituted ethyl group can be selected from:
-CXH-CX
2H; -CX
2CH
2X; -CXH-CX
3; -CX
2-CX
2H; and -CX
2CX
3, in which each X independently is the same or a different halogen atom in each instance.
With some embodiments, the halo-substituted ethyl group is selected from: -CX
2CH
2X; -CX
2-CX
2H; and -CX
2CX
3.
[0085] The halo group of each pendent halo-substituted group is, with some embodiments,
independently selected from fluorine, chlorine, bromine and/or iodine. With some further
embodiments, each halo group of each pendent halo-substituted group is independently
selected from fluorine, chlorine and/or bromine. With some additional embodiments,
each halo group of each pendent halo-substituted group is independently selected from
fluorine and/or chlorine. In accordance with some further additional embodiments of
the present invention, the halo group of each pendent halo-substituted group is fluorine.
[0086] The pi-conjugation extending group bonded to the 6-position, the 7-position, and/or
the 11-position of the indeno-fused naphthopyran represented by Formula (I) is, with
some embodiments, in each case independently represented by the following Formula
(II') or Formula (III):
-C(R
30)=C(R
31)(R
32) (II')
or
-C≡C-R
33 (III)
[0087] With reference to Formula (II') and Formula (III), R
30, R
31 and R
32 are each independently, amino, dialkyl amino, diaryl amino, acyloxy, acylamino, a
substituted or unsubstituted C
1-C
20 alkyl, a substituted or unsubstituted C
2-C
20 alkenyl, a substituted or unsubstituted C
2-C
20 alkynyl, halogen, hydrogen, hydroxy, oxygen, a polyol residue, a substituted or unsubstituted
phenoxy, a substituted or unsubstituted benzyloxy, a substituted or unsubstituted
alkoxy, a substituted or unsubstituted oxyalkoxy, alkylamino, mercapto, alkylthio,
a substituted or unsubstituted aryl, a substituted or unsubstituted heteroaryl, a
substituted or unsubstituted heterocyclic group.
[0088] In accordance with some embodiments, when the pi-conjugation extending group, that
is bonded to the 6-position, the 7-position, and/or the 11-position of the indeno-fused
naphthopyran represented by Formula (I), includes at least one pendent halo-substituted
group bonded thereto, there is the proviso with regard to Formulas (II') and (III),
that at least one of R
30, R
31 and R
32 is the pendent halo-substituted group, and R
33 is the pendent halo-substituted group.
[0089] The pendent halo-substituted group of the pi-conjugation extending group bonded to
the 6-position, the 7-position, and/or the 11-position of said indeno-fused naphthopyran
represented by Formula (I) is, with some embodiments, selected from halo-substituted(C
1-C
10)alkyl, halo-substituted(C
2-C
10)alkenyl, halo-substituted(C
2-C
10)alkynyl, halo-substituted(C
1-C
10)alkoxy and halo-substituted(C
3-C
10)cycloalkyl. The halo group of each pendent halo-substituted group is, with some embodiments,
independently selected from fluorine, chlorine, bromine and iodine.
[0090] Examples of pendent halo-substituted(C
1-C
10)alkyls include, but are not limited to, halo-substituted methyl, halo-substituted
ethyl, linear or branched halo-substituted propyl, linear or branched halo-substituted
butyl, linear or branched halo-substitutedpentyl, linear or branched halo-substituted
hexyl, linear or branched halo-substitutedheptyl, linear or branched halo-substituted
octyl, linear or branched halo-substituted nonyl, and linear or branched halo-substituted
decyl. Examples of pendent halo-substituted(C
2-C
10)alkenyls include, but are not limited to, halo-substituted ethenyl, linear or branched
halo-substituted propenyl, linear or branched halo-substituted butenyl, linear or
branched halo-substituted pentenyl, linear or branched halo-substituted hexenyl, linear
or branched halo-substituted heptenyl, linear or branched halo-substituted octenyl,
linear or branched halo-substituted nonenyl, and linear or branched halo-substituted
decenyl. Examples of pendent halo-substituted (C
2-C
10)alkynyls, include, but are not limited to, halo-substitutedethynyl, linear or branched
halo-substituted propynyl, linear or branched halo-substituted butynyl, linear or
branched halo-substituted pentynyl, linear or branched halo-substituted hexynyl, linear
or branched halo-substituted heptynyl, linear or branched halo-substituted octynyl,
linear or branched halo-substituted nonynyl, and linear or branched halo-substituted
decynyl. Examples of pendent halo-substituted(C
1-C
10)alkoxys include, but are not limited to, halo-substituted methylalkoxy, halo-substituted
ethylaclkoxy, linear or branched halo-substituted propylalkoxy, linear or branched
butylalkoxy, linear or branched pentylalkoxy, linear or branched hexylalkoxy, linear
or branched heptylalkoxy, linear or branched octylalkoxy, linear or branched nonylalkoxy
and linear or branched decylalkoxy. Examples of pendent halo-substituted(C
3-C
10)cycloalkyls include, but are not limited to, halo-substituted cyclopropyl, halo-substituted
cyclobutyl, halo-substituted cyclopentyl, halo-substituted cyclohexyl, halo-substituted
cycloheptyl, halo-substituted cyclooctyl, halo-substituted cyclononyl and halo-substituted
cyclodecyl.
[0091] The pi-conjugation extending group bonded to the 6-position, the 7-position, and/or
the 11-position of the indeno-fused naphthopyran represented by Formula (I) is in
each case independently, with some embodiments: substituted or unsubstituted aryl;
or substituted or unsubstituted heteroaryl.
[0092] Examples of aryl groups from which the substituted or unsubstituted aryl group can
be selected, include, but are not limited to, phenyl, naphthyl, fluorenyl, anthracenyl
and phenanthracenyl. With some embodiments of the present invention, the pi-conjugation
extending group bonded to the 6-position, the 7-position, and/or the 11-position of
the indeno-fused naphthopyran is independently selected from substituted and unsubstituted
phenyl. Examples of heteroaryl groups from which the substituted or unsubstituted
heteroaryl group can be selected, include, but are not limited to, pyridyl, quinolinyl,
isoquinolinyl, bipyridyl, pyridazinyl, cinnolinyl, phthalazinyl, pyrimidinyl, quinazolinyl,
pyrazinyl, quinoxalinyl, phenanthrolinyl, triazinyl, pyrrolyl, indolyl, furfuryl,
benzofurfuryl, thienyl, benzothienyl, pyrazolyl, indazolyl, imidazolyl, benzimidazolyl,
triazolyl, benzotriazolyl, tetrazolyl, oxazolyl, benzoxazolyl, isoxazolyl, benzisoxazolyl,
thiazolyl, benzothiazolyl, isothiazolyl, benzisothiazolyl, thiadiazolyl, benzothiadiazolyl,
thiatriazolyl, purinyl, carbazolyl and azaindolyl.
[0093] With some embodiments, the substituted or unsubstituted aryl and substituted or unsubstituted
heteroaryl bonded to the 6-position, the 7-position, and/or the 11-position of the
indeno-fused naphthopyran represented by Formula (I) each independently include a
pendent halo-substituted group, which can be selected from one or more pendent halo-substituted
groups as described previously herein.
[0094] The substituted aryl and said substituted heteroaryl, bonded to the 6-position, the
7-position, and/or the 11-position of the indeno-fused naphthopyran represented by
Formula (I), are in each case, with some embodiments, independently substituted with
at least one member selected from the group consisting of substituted or unsubstituted
alkyl, substituted or unsubstituted alkoxy, substituted or unsubstituted oxyalkoxy,
amide, substituted or unsubstituted amino, substituted or unsubstituted aryl, substituted
or unsubstituted heteroaryl, azide, carbonyl, carboxy, ester, ether, halogen, hydroxy,
polyol residue, substituted or unsubstituted phenoxy, substituted or unsubstituted
benzyloxy, cyano, nitro, sulfonyl, thiol, substituted or unsubstituted heterocyclic
group, provided that if the aryl group or the heteroaryl group comprises more than
one substituent, each substituent is independently chosen.
[0095] In accordance with some additional embodiments, the indeno-fused naphthopyran represented
by Formula (I) is free of a pi-conjugation extending group bonded to the 6-position
and the 7-position, and the indeno-fused naphthopyran represented by Formula (I) further
includes an ether group bonded to the 6-position and/or the 7-position of the indeno-fused
naphthopyran. The ether group bonded to the 6-position and/or the 7-position of the
indeno-fused naphthopyran, with some embodiments, is in each case independently represented
by the following Formula (IV):
-OR
8' (IV)
[0096] With reference to Formula (IV), R
8' is, with some embodiments, phenyl(C
1-C
3)alkyl, C
1-C
6 alkyl, mono(C
1-C
6)alkyl substituted phenyl(C
1-C
3)alkyl, mono(C
1-C
6)alkoxy substituted phenyl(C
1-C
3)alkyl, C
1-C
6 alkoxy(C
2-C
4)alkyl, C
3-C
7 cycloalkyl, mono(C
1-C
4)alkyl substituted C
3-C
7 cycloalkyl, C
1-C
6 chloroalkyl, C
1-C
6 fluoroalkyl, allyl.
[0097] With further reference to Formula (IV), and in accordance with some embodiments,
R
8' is the group, -CH(R
9')Q, wherein R
9' is hydrogen or C
1-C
3 alkyl, and Q is -CN, -CF
3 or -COOR
10', wherein R
10' is hydrogen or C
1-C
3 alkyl.
[0098] In accordance with some additional embodiments, the ether group bonded to the 6-position
and/or the 7-position of the indeno-fused naphthopyran represented by Formula (I),
is in each case independently selected from linear or branched C
1-C
6 alkyl ether. For example, R
8' of Formula (III) with some embodiments, is selected from methyl, ethyl, linear or
branched propyl, linear or branched butyl, linear or branched pentyl and linear or
branched hexyl. With some further embodiments of the present invention, R
8' of Formula (III) is selected from linear or branched C
1-C
3 alkyl (e.g., methyl, ethyl and linear or branched propyl).
[0099] In accordance with some additional embodiments, the indeno-fused naphthopyran represented
by Formula (I) is free of a pi-conjugation extending group bonded to the 6-position
and the 7-position of the indeno-fused naphthopyran, and the indeno-fused naphthopyran
further includes an amino group bonded to the 6-position and/or the 7-position of
the indeno-fused naphthopyran.
[0100] The indeno-fused naphthopyran represented by Formula (I), with some embodiments is
free of a pi-conjugation extending group bonded to the 6-position and the 7-position,
and further includes, in addition to the pi-conjugation extending group bonded to
the 11-position thereof, as described previously herein: (i) an ether group bonded
to the 6-position thereof, as described previously herein; and/or (ii) an amino group
bonded to the 7-position thereof, as described above and in further detail herein
below.
[0101] The indeno-fused naphthopyran represented by Formula (I), with some further embodiments
is free of a pi-conjugation extending group bonded to the 6-position and the 7-position
thereof, and the indeno-fused naphthopyran further includes an amino group bonded
to the 6-position and/or the 7-position thereof (in addition to a pi-conjugation extending
group bonded to the 11-position thereof).
[0102] The amino group bonded to the 6-position and/or the 7-position of the indeno-fused
naphthopyran represented by Formula (I), with some embodiments, is in each case independently
selected from the following groups of amino groups (1), (2), and (3).
[0103] With some embodiments, the amino group bonded to the 6-position and/or the 7-position
of the indeno-fused naphthopyran represented by Formula (I) is independently chosen
from (1) -N(R
15)R
16 wherein R
15 and R
16 are each selected from the group consisting of hydrogen provided that only one of
R
15 and R
16 is hydrogen, C
1-C
8 alkyl, phenyl, naphthyl, heteroaromatic groups, furanyl, benzofuran-2-yl, benzofuran-3-yl,
thienyl, benzothien-2-yl, benzothien-3-yl, dibenzofuranyl, dibenzothienyl, benzopyridyl
and fluorenyl, C
1-C
8 alkylaryl, C
3-C
20 cycloalkyl, C
4-C
20 bicycloalkyl, C
5-C
20 tricycloalkyl and C
1-C
20 alkoxyalkyl, wherein said aryl group is phenyl or naphthyl.
[0104] The amino group bonded to the 6-position and/or the 7-position of the indeno-fused
naphthopyran represented by Formula (I) is, with some embodiments, independently chosen
from (2) a nitrogen containing ring represented by the following Formula (V),

[0105] With reference to Formula (V), Y is independently selected for each p and each m
from the group consisting of -CH
2-, -CH(R
17)-, -C(R
17)(R
17)-, -CH(aryl)-, -C(aryl)
2-, and -C(R
17)(aryl)-, and X is selected from the group consisting of -Y-, - O-, -S-, -S(O)-, -S(O
2)-, -NH-, -NR
17- and -N-aryl, wherein R
17 is in each instance independently selected from C
1-C
6 alkyl, said aryl substituent is phenyl or naphthyl, m is the integer 1, 2 or 3, and
p is the integer 0, 1, 2, or 3, provided that when p is 0, X is Y.
[0106] The amino group bonded to the 6-position and/or the 7-position of the indeno-fused
naphthopyran represented by Formula (I) is, with some additional embodiments, independently
chosen from (3) a group represented by the following Formulas (VI) and (VII):

[0107] With reference to Formulas (VI) and (VII), R
19, R
20 and R
21 are each hydrogen, C
1-C
5 alkyl, phenyl or naphthyl, or the groups R
19 and R
20 together form a ring of 5 to 8 carbon atoms, and R
18 is C
1-C
6 alkyl, C
1-
6 alkoxy, fluoro or chloro.
[0108] With some embodiments of the present invention, the amino group bonded to the 6-position
and/or the 7-position of the indeno-fused naphthopyran represented by Formula (I)
is independently represented by the following Formulas-(VIII) and - (IX).

[0109] With reference to Formulas-(XI) and -(XII), R
17 is in each instance independently selected from hydrogen or C
1-C
6 alkyl, and correspondingly, the amino group bonded to the 6-position and/or the 7-position
of the indeno-fused naphthopyran is independently selected from substituted or unsubstituted
piperidenyl (e.g., Formula-XI), and substituted or unsubstituted morpholinyl (e.g.,
Formula-XII).
[0110] In accordance with some further embodiments, the amino group bonded to the 6-position
and/or the 7-position of the indeno-fused naphthopyran represented by Formula (I)
is independently selected from substituted and unsubstituted piperidenyl, such as
represented by Formula (VIII).
[0111] The 13-position of the indeno-fused naphthopyran represented by Formula (I) is free
of spiro-substituents (i.e., free of spiro-cyclic groups), with some embodiments.
The 13-position of the indeno-fused naphthopyran being "free of spiro-substituents"
means that if the 13-position of the indeno-fused naphthopyran is di-substituted,
the substituent groups do not together form a spiro group (i.e., a spiro-cyclic group).
As used herein the phrase "free of spiro-cyclic groups at the 13-position" means that
if the 13-position of the indeno-fused naphthopyran is di-substituted, the substituent
groups do not together form a spiro-cyclic group.
[0112] With some embodiments of the present invention, the 5-, 8-, 9-, 10-, and 12-positions
of the indeno-fused naphthopyran represented by Formula (I) each independently have
bonded thereto hydrogen, hydrocarbyl, or substituted hydrocarbyl, each independently
and optionally interrupted with at least one of -O-, -S-, -C(O)-, -C(O)O-, -S(O)-,
-SO
2-, -N=N-, -N(R
11')- where R
11' is selected from hydrogen, hydrocarbyl or substituted hydrocarbyl, -Si(OR
8')w(R
8')
t-, where w and t are each independently selected from 0 to 2, provided that the sum
of w and t is 2, and each R
8' is independently selected from hydrogen, hydrocarbyl and substituted hydrocarbyl,
and combinations of two or more thereof.
[0113] With some further embodiments of the present invention, the 5-, 8-, 9-, 10-, and
12-positions of the indeno-fused naphthopyran represented by Formula (I) each independently
have bonded thereto hydrogen; C
1-C
6 alkyl; chloro; fluoro; C
3-C
7 cycloalkyl; a substituted or unsubstituted phenyl, the phenyl substituents being
C
1-C
6 alkyl or C
1-C
6 alkoxy; -OR
10' or -OC(=O)R
10' wherein R
10' is S, hydrogen, amine, C
1-C
6 alkyl, phenyl(C
1-C
3)alkyl, mono(C
1-C
6)alkyl substituted phenyl(C
1-C
3)alkyl, mono(C
1-C
6)alkoxy substituted phenyl(C
1-C
3)alkyl, (C
1-C
6)alkoxy(C
2-C
4)alkyl, C
3-C
7 cycloalkyl or mono(C
1-C
4)alkyl substituted C
3-C
7 cycloalkyl; or -N(R
11')R
12', wherein R
11' and R
12' are each independently hydrogen, C
1-C
8 alkyl, phenyl, naphthyl, furanyl, benzofuran-2-yl, benzofuran-3-yl, thienyl, benzothien-2-yl,
benzothien-3-yl, dibenzofuranyl, dibenzothienyl, benzopyridyl and fluorenyl, C
1-C
8 alkylaryl, C
3-O
20 cycloalkyl, C
4-C
20 bicycloalkyl, C
5-C
20 tricycloalkyl or C
1-C
20 alkoxyalkyl, or R
11' and R
12' come together with the nitrogen atom to form a C
3-C
20 hetero-bicycloalkyl ring or a C
4-C
20 hetero-tricycloalkyl ring.
[0114] The 5-, 8-, 9-, 10-, and 12-positions of the indeno-fused naphthopyran represented
by Formula (I) each independently have bonded thereto, with some embodiments, hydrogen;
or a nitrogen containing ring represented by Formula (V) as described previously herein.
[0115] The 13-position of the indeno-fused naphthopyran represented by Formula (I), with
some embodiments, has bonded thereto two groups which are each independently chosen
from: hydrogen; hydroxy; C
1-C
6 alkyl; C
3-C
7 cycloalkyl; allyl; a substituted or unsubstituted phenyl or benzyl, wherein each
of said phenyl and benzyl substituents is independently C
1-C
6 alkyl or C
1-C
6 alkoxy; chloro; fluoro; a substituted or unsubstituted amino; -C(O)R
9' wherein R
9' is hydrogen, hydroxy, C
1-C
6 alkyl, C
1-C
6 alkoxy, an unsubstituted, mono- or di-substituted phenyl or naphthyl wherein each
of said substituents is independently C
1-C
6 alkyl or C
1-C
6 alkoxy, phenoxy, mono- or di-(C
1-C
6)alkyl substituted phenoxy, mono- or di-(C
1-C
6)alkoxy substituted phenoxy, amino, mono- or di-(C
1-C
6)alkylamino, phenylamino, mono- or di-(C
1-C
6)alkyl substituted phenylamino or mono- or di-(C
1-C
6)alkoxy substituted phenylamino; and -OR
18 wherein R
18 is C
1-C
6 alkyl, phenyl(C
1-C
3)alkyl, mono(C
1-C
6)alkyl substituted phenyl(C
1-C
3)alkyl, mono(C
1-C
6)alkoxy substituted phenyl(C
1-C
3)alkyl, C
1-C
6 alkoxy(C
2-C
4)alkyl, C
3-C
7 cycloalkyl, mono(C
1-C
4)alkyl substituted C
3-C
7 cycloalkyl, C
1-C
6 chloroalkyl, C
1-C
6 fluoroalkyl, allyl or -CH(R
19)T wherein R
19 is hydrogen or C
1-C
3 alkyl, T is CN, CF
3 or COOR
20 wherein R
20 is hydrogen or C
1-C
3 alkyl, or wherein R
18 is -C(=O)U wherein U is hydrogen, C
1-C
6 alkyl, C
1-C
6 alkoxy, an unsubstituted, mono- or di-substituted phenyl or naphthyl, wherein each
of said substituents are independently C
1-C
6 alkyl or C
1-C
6 alkoxy, phenoxy, mono- or di-(C
1-C
6)alkyl substituted phenoxy, mono- or di-(C
1-C
6)alkoxy substituted phenoxy, amino, mono- or di-(C
1-C
6)alkylamino, phenylamino, mono- or di-(C
1-C
6)alkyl substituted phenylamino or mono- or di-(C
1-C
6)alkoxy substituted phenylamino. With some further embodiments, the two groups bonded
to position-13 together form an oxo group.
[0116] The 3-position of the indeno-fused naphthopyran represented by Formula (I), with
some embodiments, has bonded thereto a B group and a B' group, which are each independently
chosen from, with some embodiments, from: hydrogen; an unsubstituted, mono-, di- or
tri-substituted aryl group; 9-julolidinyl; an unsubstituted, mono- or di-substituted
heteroaromatic group chosen from pyridyl, furanyl, benzofuran-2-yl, benzofuran-3-yl,
thienyl, benzothien-2-yl, benzothien-3-yl, dibenzofuranyl, dibenzothienyl, carbazoyl,
benzopyridyl, indolinyl and fluorenyl. The aryl and heteroaromatic substituents are,
with some embodiments, each independently selected from: hydroxy, aryl, mono- or di-(C
1-C
12)alkoxyaryl, mono- or di-(C
1-C
12)alkylaryl, haloaryl, C
3-C
7 cycloalkylaryl, C
3-C
7 cycloalkyl, C
3-C
7 cycloalkyloxy, C
3-C
7 cycloalkyloxy(C
1-C
12)alkyl, C
3-C
7 cycloalkyloxy(C
1-C
12)alkoxy, aryl(C
1-C
12)alkyl, aryl(C
1-C
12)alkoxy, aryloxy, aryloxy(C
1-C
12)alkyl, aryloxy(C
1-C
12)alkoxy, mono- or di-(C
1-C
12)alkylaryl(C
1-C
12)alkyl, mono- or di-(C
1-C
12)alkoxyaryl(C
1-C
12)alkyl, mono- or di-(C
1-C
12)alkylaryl(C
1-C
12)alkoxy, mono- or di-(C
1-C
12)alkoxyaryl(C
1-C
12)alkoxy, amino, mono- or di-(C
1-C
12)alkylamino, diarylamino, piperazino, N-(C
1-C
12)alkylpiperazino, N-arylpiperazino, aziridino, indolino, piperidino, morpholino, thiomorpholino,
tetrahydroquinolino, tetrahydroisoquinolino, pyrrolidyl, C
1-C
12 alkyl, C
1-C
12 haloalkyl, C
1-C
12 alkoxy, mono(C
1-C
12 )alkoxy(C
1-C
12 )alkyl, acryloxy, methacryloxy, halogen, or -C(=O)R
21 wherein R
21 is -OR
22, -N(R
23)R
24, piperidino or morpholino, wherein R
22 is allyl, C
1-C
6 alkyl, phenyl, mono(C
1-C
6)alkyl substituted phenyl, mono(C
1-C
6)alkoxy substituted phenyl, phenyl(C
1-C
3)alkyl, mono(C
1-C
6)alkyl substituted phenyl(C
1-C
3)alkyl, mono(C
1-C
6)alkoxy substituted phenyl(C
1-C
3)alkyl, C
1-C
6 alkoxy(C
2-C
4)alkyl or C
1-C
6 haloalkyl, and R
23 and R
24 are each independently C
1-C
6 alkyl, C
5-C
7 cycloalkyl or a substituted or unsubstituted phenyl, the phenyl substituents independently
being C
1-C
6 alkyl or C
1-C
6 alkoxy.
[0117] The B and B' groups bonded to position-3 of the indeno-fused naphthopyran represented
by Formula-(I), with some further embodiments, are each independently selected from:
hydrogen; and an unsubstituted or mono-substituted group chosen from pyrazolyl, imidazolyl,
pyrazolinyl, imidazolinyl, pyrrolinyl, phenothiazinyl, phenoxazinyl, phenazinyl and
acridinyl, the substituents being C
1-C
12 alkyl, C
1-C
12 alkoxy, phenyl or halogen; and a mono-substituted phenyl, in which the phenyl has
a substituent located at the para position thereof, the substituent being a dicarboxylic
acid residue or derivative thereof, a diamine residue or derivative thereof, an amino
alcohol residue or derivative thereof, a polyol residue or derivative thereof, -(CH
2)-, -(CH
2)
t- or -[O-(CH
2)
t]
k-, wherein "t" may range form 2 to 6 and "k" may range from 1 to 50, wherein the substituent
may be connected to an aryl group on another photochromic material.
[0118] The B and B' groups bonded to position-3 of the indeno-fused naphthopyran represented
by Formula-(I), with some further embodiments, are each independently selected from;
hydrogen; and a group represented by the following general formulas (X) and/or (XI):

[0119] With reference to formulas (X) and (XI) above, and in accordance with some embodiments,
V represents -CH
2- and -O-. Examples of groups that W can represent, with some embodiments, include
oxygen and substituted nitrogen, provided that if W is a substituted nitrogen, V is
-CH
2-. Non-limiting examples of nitrogen substituents include hydrogen, C
1-C
12 alkyl and C
1-C
12 acyl. With some further embodiments, "s" can range from 0 to 2, and, if s is greater
than one, each group represented by R
25 can be the same as or different from one or more other R
25 groups. Non-liming examples of groups that R
25 represents include C
1-C
12 alkyl, C
1-C
12 alkoxy, hydroxy and halogen. Non-limiting examples of groups that R
26 and R
27 represent, with some embodiments, include hydrogen and C
1-C
12 alkyl.
[0120] The B and B' groups bonded to position-3 of the indeno-fused naphthopyran represented
by Formula-(I) with some further embodiments are each independently selected from:
hydrogen; and a group represented by the following Formula (XII):

[0121] With reference to Formula (XII) above, R
28 is chosen from, with some embodiments, hydrogen and C
1-C
12 alkyl. The R
29 group of Formula (XII) is chosen from, with some embodiments, an unsubstituted, mono-
or di-substituted naphthyl, phenyl, furanyl or thienyl, said substituents being C
1-C
12 alkyl, C
1-C
12 alkoxy or halogen.
[0122] The B and B' groups bonded to position-3 of the indeno-fused naphthopyran represented
by Formula-(I), with some embodiments, together form a fluoren-9-ylidene group, or
a mono- or di-substituted fluoren-9-ylidene group. Each of the fluoren-9-ylidene substituents
are, with some embodiments, independently selected from C
1-C
12 alkyl, C
1-C
12 alkoxy, or halogen.
[0123] In accordance with some embodiments, the indeno-fused naphthopyrans represented by
Formula (I) are chosen from one or more indeno-fused naphthopyrans represented by
the following Formulas (I-1) through (I-7), and combinations of two or more thereof:
3,3-bis-(4-methoxyphenyl)-6-methoxy-7-piperidino-11-(4-trifluoromethyl)phenyl-13,13-dimethyl-3H,13H-indeno[2,1-f]naphtho[1,2-b]pyran,
which is represented by the following Formula (I-1),

3-(4-methoxyphenyl)-3-(4-morpholinophenyl)-6-methoxy-7-piperidino-11-phenyl-13,13-dimethyl-3H,13H-indeno[2,1-f]naphtho[1,2-b]pyran,
which is represented by the following Formula (I-2),

3,3-bis-(4-methoxyphenyl)-6-methoxy-7-morpholino-11-(4-trifluoromethyl)phenyl-13,13-dimethyl-3H,13H-indeno[2,1-f]naphtho[1,2-b]pyran,
which is represented by the following Formula (I-3),

3,3-bis-(4-methoxyphenyl)-6,7-dimethoxy-11-(4-trifluoromethyl)phenyl-13,13-dimethyl-3H,13H-indeno[2,1-f]naphtho[1,2-b]pyran,
which is represented by the following Formula (I-4),

3-(4-methoxyphenyl)-3-(4-morpholinophenyl)-6-methoxy-7-piperidino-11-(2-trifluoromethyl)phenyl-13,13-dimethyl-3H,13H-indeno[2,1-f]naphtho[1,2-b]pyran,
which is represented by the following Formula (I-5),

3-(4-butoxyphenyl)-3-(4-methoxyphenyl)-7-methoxy-11-phenyl-13,13-dimethyl-3H,13H-indeno[2,1-f]naphtho[1,2-b]pyran,
which is represented by the following Formula (I-6),

and
3-(4-(2-((1,1,1,5,5,5-hexamethyl-3-((trimethylsilyl)oxy)trisiloxan-3-yl)oxy)ethoxy)phenyl)-3-(4-morpholinophenyl)-7-methoxy-11-phenyl-13,13-dimethyl-3H,13H
indeno[2,1-f] naphtho[1,2-b]pyran, which is represented by the following Formula (I-7),

[0124] In accordance with some embodiments of the present invention, the photochromic compound,
of the photochromic coating layer, includes a reaction product of: (a) at least one
ring-opening cyclic monomer chosen from a cyclic ester, a cyclic carbonate, and combinations
thereof; and (b) a photochromic initiator.
[0125] With some embodiments, the cyclic ester from which the ring-opening cyclic monomer
can be selected is represented by the following Formula (XIII) and the cyclic carbonate
from which the ring-opening cyclic monomer can be selected is represented by the following
Formula (XIV):

[0126] With reference to Formula (XIII) and Formula (XIV), R
f and R
e are each independently selected from divalent hydrocarbyl and substituted divalent
hydrocarbyl, each optionally interrupted with at least one -O-. With some embodiments
there is the proviso that any such optional interrupting divalent -O-: (i) is not
bonded to a carbonyl carbon in the case of Formula (XIII); and (ii) is not bonded
to another oxygen in the case of both of Formula (XIII) and Formula (XIV). With some
further embodiments, R
f and R
e are each independently selected from optionally substituted divalent linear or branched
C
2-C
20 alkyl, or optionally substituted divalent linear or branched C
2-C
10 alkyl, or optionally substituted divalent linear or branched C
2-C
5 alkyl, where the optional substituents are independently selected from those substituents
as described previously herein with regard to substituted hydrocarbyl groups.
[0127] Additional examples of cyclic esters and cyclic carbonates from which the ring-opening
cyclic monomer can be selected include, but are not limited to, those described at
column 10, line 47 through column 11, line 47 of Unites States Patent No.
7,465,415.
[0128] Each ring-opening cyclic monomer (a), that is reacted with the photochromic initiator
(b), with some embodiments, is chosen from a cyclic ester, and each cyclic ester is
chosen from epsilon-caprolactone, delta-valerolactone, and combinations thereof.
[0129] The photochromic initiator (b) includes, with some embodiments, at least one functional
group that is adapted to initiate ring-opening of the at least one ring-opening cyclic
monomer (a). In accordance with some further embodiments, each functional group of
the photochromic initiator (b) is chosen from an alcohol, an amine, a carboxylic acid,
a silanol, a thiol, salts thereof, and combinations thereof.
[0130] Each functional group of the photochromic initiator (b), with some embodiments, is
chosen from a primary alcohol group, a secondary alcohol group, salts thereof, and
combinations thereof.
[0131] The photochromic initiator (b), with some embodiments, is chosen from the indeno-fused
naphthopyran represented by Formula (I) above, which further includes at least one
functional group that is adapted to initiate ring-opening of the at least one ring-opening
cyclic monomer (a).
[0132] In accordance with some further embodiments, the photochromic coating layer includes
at least one photochromic compound, which includes at least one ring-opened group
represented by the following Formula (II),

[0133] In accordance with some additional embodiments, the photochromic coating layer includes
at least one indeno-fused napthopyran represented by Formula (I), which further includes
at least one ring-opened group represented by Formula (II) above.
[0134] Independently for each ring-opened group represented by Formula (II): L
1 is a bond or a multivalent hydrocarbyl group or a multivalent substituted hydrocarbyl
group, each optionally interrupted with at least one of -O-, -S-, -C(O)-, -C(O)O-,-OC(O)O-,
-S(O)-, -SO
2-, -N(R
9)- and -Si(R
9)(R
10)- wherein R
9 and R
10 are each independently selected from hydrocarbyl and substituted hydrocarbyl, and
combinations of two or more thereof; L
2, independently for each t, is chosen from -O-, -N(R
b)-, and -S-, wherein R
b, independently for each t, is chosen from hydrogen, hydrocarbyl, and substituted
hydrocarbyl; R
a, independently for each s, is chosen from a ring-opened cyclic ester monomer and
a ring-opened cyclic carbonate monomer; E, independently for each t, is chosen from
hydrogen, hydrocarbyl and substituted hydrocarbyl each optionally interrupted with
at least one of -O-, -S-, -C(O)-, -C(O)O-, -OC(O)O-, -S(O)-, -SO
2-, -N(R
9)- and -Si(R
9)(R
10)-wherein R
9 and R
10 are each independently selected from hydrocarbyl and substituted hydrocarbyl, and
combinations of two or more thereof; subscript s, independently for each t, is from
1 to 500, or from 1 to 300, or from 1 to 200, or from 1 to 150, or from 1 to 100,
or from 1 to 50, or from 1 to 25; and subscript t is from 1 to 20, or from 1 to 15,
or from 1 to 10, or from 1 to 5, or from 1 to 3.
[0135] Each ring-opened group represented by Formula (II) is, with some further embodiments,
independently bonded to at least one of the 3-position, the 5-position, the 8-position,
the 9-position, the 10-position, the 12-position, and/or the 13-position of the indeno-fused
naphthopyran represented by Formula (I). Each ring-opened group represented by Formula
(II) is, with some additional embodiments, independently bonded to at least one of
the 3-position, the 5-position, the 6-position, the 7-position, the 8-position, the
9-position, the 10-position, the 11-position, the 12-position, and/or the 13-position
of the indeno-fused naphthopyran represented by Formula (I); provided that a pi-conjugation
extending group is bonded to at least one of the 6-position, the 7-position, and/or
the 11-position of the indeno-fused naphthopyran represented by Formula (II).
[0136] With further reference to the ring-opened group represented by Formula (II), and
in accordance with some embodiments, the multivalent groups from which L
1 is selected include, but are not limited to, multivalent versions (or forms) of those
groups as described previously herein that can be bonded to the 3-position, the 5-position,
the 8-position, the 9-position, the 10-position, the 12-position, and the 13-position
of the indeno-fused naphthopyran represented by Formula (I).
[0137] With some embodiments, L
1 of Formula (II) is or includes one or more residues of: linear or branched C
1-C
20 alkylene oxide; poly(linear or branched C
1-C
20 alkylene oxide) having from 2 to 100, or from 2 to 50, or from 2 to 25, or from 2
to 10, or from 2 to 5 repeat units; glycerol; trimethylol propane; di-trimethylolpropane;
pentaerythritol; di-pentaerythritol; and combinations of two or more thereof, including
alternating combinations of two or more thereof.
[0138] With additional reference to the ring-opened group represented by Formula (II), and
in accordance with some embodiments, R
b of the divalent linking group -N(R
b)- from which L
2 can be selected, independently for each t is chosen from hydrogen, linear or branched
C
1-C
20 alkyl, or linear or branched C
1-C
10 alkyl, or linear or branched C
1-C
6 alkyl.
[0139] With additional further reference to the ring-opened group represented by Formula
(II), and in accordance with some embodiments, the ring-opened cyclic ester monomer
and the ring-opened cyclic carbonate monomer from which R
a can be independently selected for each s are formed from (or are ring-opened versions
of) cyclic ester monomers represented by Formula (XIII) and cyclic carbonate monomers
represented by Formula (XIV) as described previously herein.
[0140] With some embodiments, R
a independently for each s is chosen from ring-opened epsilon-caprolactone and ring-opened
delta-valerolactone.
[0141] With further reference to the ring-opened group represented by Formula (II), and
in accordance with some embodiments, E, independently for each t, is chose from: hydrogen;
(meth)acrylic acid ester; allyl ether; allyl carbonate; vinyl ether; vinyl carbonate;
optionally substituted linear or branched C
1-C
20 alkyl; optionally substituted aryl; optionally substituted linear or branched C
1-C
20 carboxylic acid ester; optionally substituted aryl carboxylic acid ester; linear
or branched C
1-C
20 alkyl ether; poly(linear or branched C
1-C
20 alkylene ether); optionally substituted linear or branched C
1-C
20 alkyl urethane; optionally substituted linear or branched C
1-C
20 alkyl thiourethane; optionally substituted aryl urethane; optionally substituted
aryl thiourethane; and optionally substituted linear or branched C
1-C
20 alkyl trialkoxysilyl. The optional substituents of the groups from which E can be
selected, with some embodiments, are each independently selected from those substituents
as described previously herein with regard to substituted hydrocarbyl groups.
[0142] Photochromic compounds that include at least one ring-opened group represented by
the following Formula (II) can, with some embodiments, be prepared in accordance with
art-recognized methods. With some embodiments, photochromic compounds that include
at least one ring-opened group represented by Formula (II) are prepared by reacting
a photochromic initiator and a ring-opening cyclic monomer, each as described previously
herein, in the presence of a catalytic amount of a catalyst. With some embodiments,
the catalyst is chosen from aluminum isopropoxide, triethyl aluminum, tin(II)2-ethylhexanoate,
trifluoro acetic acid, enzymes, potassium or an appropriate salt thereof, trifluoromethanesulfonic
anhydride, and combinations thereof.
[0144] With reference to Formulas (XV-1) through (XV-6), and in accordance with some embodiments,
n and m are in each case independently greater than 0 and less than or equal to 100,
such as from 5 to 100, or from 8 to 100, or from 10 to 100, or from 15 to 100, or
from 20 to 100, or from 25 to 100, or from 30 to 100, or from 35 to 100, or from 40
to 100, or from 45 to 100, or from 50 to 100. With some embodiments the sum of n and
m of Formulas (XV-1) through (XV-6) is in each case independently: less than or equal
to 200; or less than or equal to 100.
[0145] With some embodiments, the photochromic material represented by Formula (XV-1) is
prepared from one mole of a photochromic initiator represented by the following Formula
(XV-1-i) and n moles of epsilon-caprolactone.

[0146] With some embodiments, the photochromic material represented by Formula (XV-2) is
prepared from one mole of a photochromic initiator represented by the following Formula
(XV-2-i) and n moles of epsilon-caprolactone.

[0147] With some embodiments, the photochromic material represented by Formula (XV-3) is
prepared from one mole of a photochromic initiator represented by the following Formula
(XV-3-i) and n moles of epsilon-caprolactone, and then subsequently m moles of delta-valerolactone.

[0148] With some embodiments, the photochromic material represented by Formula (XV-4) is
prepared from one mole of a photochromic initiator represented by the following Formula
(XV-4-i) and n moles of epsilon-caprolactone, and then subsequently m moles of delta-valerolactone.

[0149] With some embodiments, the photochromic material represented by Formula (XV-5) is
prepared from one mole of a photochromic initiator represented by the following Formula
(XV-5-i) and n moles of epsilon-caprolactone, and then subsequently m moles of delta-valerolactone.

[0150] With some embodiments, the photochromic material represented by Formula (XV-6) is
prepared from one mole of a photochromic initiator represented by the following Formula
(XV-6-i) and n moles of epsilon-caprolactone, and then subsequently m moles of delta-valerolactone.

[0151] In accordance with some embodiments of the present invention, forming the photochromic
coating layer over at least a portion of the rear surface of the segmented multifocal
finished lens includes: (i) applying a photochromic coating composition over at least
a portion of the rear surface of the segmented multifocal finished lens, thereby forming
an applied photochromic coating composition over at least the portion of the rear
surface of the segmented multifocal finished lens; and converting the applied photochromic
coating composition to the photochromic coating layer residing over at least said
portion of said rear surface of the segmented multifocal finished lens.
[0152] The photochromic coating composition can be applied over at least a portion of the
rear surface of the segmented multifocal finished lens by art-recognized methods.
With some embodiments, the photochromic coating composition is applied by spray methods,
curtain coating methods, spin coating methods, doctor (or draw-down) blade application
methods, and combinations thereof.
[0153] The photochromic coating composition includes, with some embodiments: one or more
photochromic compounds as described previously herein; a resin component; optionally
one or more solvents; and optionally one or more additives. Examples of solvents include,
but are not limited to, the following: propylene glycol monomethyl ether acetate and
their derivates (sold as DOWANOL solvents), acetone, amyl propionate, anisole, benzene,
butyl acetate, cyclohexane, dialkyl ethers of ethylene glycol, e.g., diethylene glycol
dimethyl ether and their derivates (sold as CELLOSOLVE solvents), diethylene glycol
dibenzoate, dimethyl sulfoxide, dimethyl formamide, dimethoxybenzene, ethyl acetate,
isopropyl alcohol, methyl cyclohexanone, cyclopentanone, methyl ethyl ketone, methyl
isobutyl ketone, methyl propionate, propylene carbonate, tetrahydrofuran, toluene,
xylene, N-methyl-2-pyrrolidone, 2-methoxyethyl ether, 3-propylene glycol methyl ether,
and mixtures thereof. The solvent can be present in the photochromic coating composition,
with some embodiments, in an amount of from 1 percent by weight to 95 percent by weight,
or from 10 percent by weight to 75 percent by weight, or from 25 percent by weight
to 60 percent by weight, in each case based on total weight of the coating composition.
[0154] The resin component of the photochromic coating composition can be a thermoplastic
resin component, a curable resin component, or a combination thereof, with some embodiments.
The thermoplastic resin component, with some embodiments, includes one or more thermoplastic
polymers. Examples of thermoplastic polymers include, but are not limited to, thermoplastic
poly(meth)acrylates, thermoplastic polyethers, thermoplastic polythioethers, thermoplastic
polyesters, thermoplastic polyamides, thermoplastic polyurethanes, thermoplastic polythiourethanes,
thermoplastic polyvinyls, thermoplastic polyolefins and combinations thereof.
[0155] When the resin component of the photochromic coating composition includes a thermoplastic
resin component, converting the applied photochromic coating composition to the photochromic
coating layer includes, with some embodiments, allowing the applied thermoplastic
photochromic coating composition to solidify. Solidification of the applied thermoplastic
photochromic coating composition includes, with some embodiments: (i) exposing the
applied thermoplastic photochromic coating composition to elevated temperature to
drive any solvent out of the applied composition; and/or (ii) cooling the applied
thermoplastic photochromic coating composition to a temperature below the melting
point of the thermoplastic resin, such as cooling to room temperature.
[0156] With some embodiments, the photochromic coating composition is a curable photochromic
coating composition, and converting the applied photochromic coating composition to
the photochromic coating layer includes curing the applied photochromic coating composition.
[0157] When the resin component of the photochromic coating composition is a curable resin
component, and correspondingly the photochromic coating composition is a curable photochromic
coating composition, the applied photochromic coating composition can be cured by
exposure to, for example: ambient temperatures, such as in the case of two component
coating compositions; elevated temperatures (e.g., 80°C to 150°C for 5 to 60 minutes),
such as in the case of thermally cured coating compositions; or actinic radiation,
such as in the case of ultraviolet light curable coating compositions.
[0158] In accordance with some embodiments, the photochromic coating composition is a curable
photochromic coating composition, and the resulting photochromic coating layer includes
an organic matrix that includes: (i) a polymer chosen from poly(meth)acrylates, polyethers,
polythioethers, polyesters, polyamides, polyurethanes, polythiourethanes, polyvinyls,
polyolefins, and combinations thereof; and (ii) a plurality of crosslink linkages
chosen from ether linkages, sulfide linkages, carboxylic acid ester linkages, carbonate
linkages (e.g., -O-C(O)-O-), urethane linkages (e.g., -N(H)-C(O)-O-), thiourethane
linkages (e.g., -N(H)-C(O)-S-), siloxane linkages, carbon-carbon linkages, and combinations
thereof. With some embodiments, carbon-carbon linkages are formed in the organic matrix
of the photochromic coating layer by free radical reactions or free radical polymerization,
such as in the case of actinic radiation curable coating compositions.
[0159] In accordance with some embodiments, the curable photochromic coating composition
includes: a (meth)acrylate copolymer having active hydrogen functionality selected
from hydroxyl, thiol, primary amine, secondary amine, and combinations thereof; optionally
a polyol that is different than the (meth)acrylate copolymer; a polyisocyanate, such
as a diisocyanate and/or a triisocyanate, each optionally blocked with a suitable
blocking or leaving group, such as, 3,5-dimethyl pyrazole; optionally one or more
solvents, as described previously herein; and optionally one or more additives, including,
but not limited to, those additives described further herein, such as, adhesion promoters,
coupling agents, ultraviolet light absorbers, thermal stabilizers, catalysts, free
radical scavengers, plasticizers, flow additives, and/or static tints or static dyes
(i.e., tints or dyes that are not photochromic).
[0160] Examples of (meth)acrylate monomers from which the active hydrogen functional (meth)acrylate
copolymer of the curable photochromic coating composition can be prepared include,
but are not limited to, C
1-C
20 (meth)acrylates, C
1-C
20 (meth)acrylates having at least one active hydrogen group selected from hydroxyl,
thiol, primary amine, and secondary amine. The C
1-C
20 groups of the (meth)acrylates can be selected from, for example, C
1-C
20 linear alkyl, C
3-C
20 branched alkyl, C
3-C
20 cycloalkyl, C
3-C
20 fused ring polycycloalkyl, C
5-C
20 aryl, and C
10-C
20 fused ring aryl.
[0161] Examples of polyols that can be present in the curable photochromic coating composition
include, but are not limited to glycerin, trimethylolpropane, trimethylolethane, trishydroxyethylisocyanurate,
pentaerythritol, ethylene glycol, propylene glycol, trimethylene glycol, butanediol,
heptanediol, hexanediol, octanediol, 4,4'-(propane-2,2-diyl)dicyclohexanol, 4,4'-methylenedicyclohexanol,
neopentyl glycol, 2,2,3-trimethylpentane-1,3-diol, 1,4-dimethylolcyclohexane, 2,2,4-trimethylpentane
diol, 4,4'-(propane-2,2-diyl)diphenol, and 4,4'-methylenediphenol. With some further
embodiments, the polyols that can be present in the curable photochromic coating composition
include, but are not limited to, polyols having number average molecular weights of
from 500 to 3500, or from 650 to 2500, or from 650 to 1500, or from 850 to 1200, or
from 850 to 1000, such as, but not limited to, polyether polyols and/or polycarbonate
polyols. Additional polyols that can be used in the curable photochromic coating composition
from which the photochromic coating layer is prepared include, but are not limited
to, art-recognized materials, such as polyether polyols and polycarbonate polyols,
described in United States Patent No.
7,465,414 at column 15, line 22 through column 16, line 62.
[0162] In accordance with some further embodiments, the polyols that can be present in the
curable photochromic coating include, but are not limited to, one or more high molecular
weight polycarbonate polyols, that have carbonate groups within the backbone thereof.
With some embodiments, such high molecular weight polycarbonate polyols are high molecular
weight polycarbonate diols. With some additional embodiments, the high molecular weight
polycarbonate polyols further include one or more linkages in the backbone that are
selected from ester linkages, ether linkages, amide linkages, and/or urethane linkages.
The high molecular weight polycarbonate polyols, with some embodiments, have Mn values
of at least 5000 g/mole, or at least 6000 g/mole, or at least 8000 g/mole. The high
molecular weight polycarbonate polyols, with some embodiments, have Mn values of less
than or equal to 20,000 g/mole, or less than or equal to 15,000 g/mole, or less than
or equal to 10,000 g/mole. In accordance with some further embodiments, the high molecular
weight polycarbonate polyols have Mn values ranging between any combination of the
above recited upper and lower v, such as from 5000 to 20,000 g/mole, or from 6000
to 15,000 g/mole, or from 8000 to 10,000 g/mole. The polycarbonate polyols, with some
embodiments, have PDI values of less than or equal to 2.0, or less than or equal to
1.5, or less than or equal to 1.3.
[0163] The high molecular weight polycarbonate polyols are, with some embodiments, prepared
by art-recognized isolation methods that involve isolating a high molecular weight
fraction of polycarbonate polyols from a feed polycarbonate polyol that is composed
of a mixture of low and high molecular weight polycarbonate polyols. With some embodiments,
the high molecular weight polycarbonate polyols are obtained by successively washing
a feed polycarbonate polyol with a suitable solvent, such as methanol, with removal
of a low molecular weight fraction between each successive washing, until a product
polycarbonate polyol is obtained that has a desirably high (or increased) molecular
weight, such as an Mn value of at least 5000 g/mole, and a desirably low (or reduced)
PDI value, such as less than or equal to 1.5. With some embodiments, the high molecular
weight polycarbonate polyols are isolated from feed aliphatic polycarbonate polyols.
Examples of commercially available feed aliphatic polycarbonate polyols, from which
the high molecular weight polycarbonate polyols are isolated, with some embodiments,
include but are not limited to: PC-1122 polycarbonate polyol, which is commercially
available from Stahl USA; ETERACOLL™ PH-200D, PH-200 and UH-200 polycarbonate polyols,
which are commercially available from Ube Chemical; DURANOL™ T5652 polycarbonate polyol,
which is commercially available from Asahi-KASEI; and/or RAVECARB™ 107 polycarbonate
polyol, which is commercially available from Enichem.
[0164] High molecular weight polycarbonate polyols that can be present in the curable photochromic
coating include, but are not limited to, those described in further detail at column
5, line 51 through column 7, line 8 of
US 8,608,988 B2,
[0165] Polyfunctional isocyanates (or polyisocyanates) that can be present in the curable
photochromic coating composition from which the photochromic coating layer is prepared
include, but are not limited to, aliphatic, aromatic, cycloaliphatic and heterocyclic
polyisocyanates, and mixtures of such polyisocyanates. Examples of polyisocyanates
that can be present in the photochromic coating composition include, but are not limited
to: toluene-2,4-diisocyanate; toluene-2,6-diisocyanate; diphenyl methane-4,4'-diisocyanate;
diphenyl methane-2,4'-diisocyanate; para-phenylene diisocyanate; biphenyl diisocyanate;
3,3'-dimethyl-4,4'-diphenylene diisocyanate; tetramethylene-1,4-diisocyanate; hexamethylene-1,6-diisocyanate;
2,2,4-trimethyl hexane-1,6-diisocyanate; lysine methyl ester diisocyanate; bis(isocyanato
ethyl)fumarate; isophorone diisocyanate; ethylene diisocyanate; dodecane-1,12-diisocyanate;
cyclobutane-1,3-diisocyanate; cyclohexane-1,3-diisocyanate; cyclohexane-1,4-diisocyanate;
methyl cyclohexyl diisocyanate; hexahydrotoluene-2,4-diisocyanate; hexahydrotoluene-2,6-diisocyanate;
hexahydrophenylene-1,3-diisocyanate; hexahydrophenylene-1,4-diisocyanate; perhydrodiphenylmethane-2,4'-diisocyanate;
perhydrodiphenylmethane-4,4'-diisocyanate; dimers and trimers of such diisocyanates
containing isocyanurate, uretidino, biruet, or allophanate linkages (such as a trimer
of isophorone diisocyanate); and mixtures and/or combinations of two or more thereof.
Further examples of polyisocyanates that can be present in the photochromic coating
composition include, but are not limited to those described in United States Patent
No.
7,465,414 at column 16, line 63 through column 17, line 38.
[0166] Catalysts that catalyze the formation of urethane linkages that can be used in the
photochromic coating composition from which the photochromic coating layer is prepared
include, but are not limited to, art-recognized materials, such as one or more stannous
salts of an organic acid, examples of which include, but are not limited to, stannous
octoate, dibutyl tin dilaurate, dibutyl tin diacetate, dibutyl tin mercaptide, dibutyl
tin dimaleate, dimethyl tin diacetate, dimethyl tin dilaurate and 1,4-diazabicyclo[2.2.2]octane.
Additional classes of catalysts include, but are not limited to, bismuth salts of
organic acids, such as bismuth 2-ethylhexanoate, and zinc-based catalysts. The catalyst
is present in the photochromic coating composition, with some embodiments, in an amount
that is at least sufficient to catalyze the formation of urethane linkages under the
particular cure conditions that are employed. With some embodiments, the catalyst
is a stannous salt of an organic acid, which is present in an amount of from 0.0005-0.02
parts per 100 parts of the polyurethane-forming components. Further non-limiting examples
of components, such as polyols, polyisocyanates, and catalysts, that can, with some
embodiments, be used with polyurethane coating compositions from which the photochromic
coating compositions of the method of the present invention can be selected, are described
in
US 4,889,413 and
US 6,187,444 B1.
[0167] The photochromic coating composition can further include at least one additive that,
with some embodiments, is capable of facilitating one or more of the processing, the
properties, or the performance of the photochromic coating composition and resulting
photochromic coating layer. Non-limiting examples of such additives include static
dyes, photoinitiators, thermal initiators, polymerization inhibitors, light stabilizers
(such as, but not limited to, ultraviolet light absorbers and light stabilizers, such
as hindered amine light stabilizers (HALS)), heat stabilizers, mold release agents,
rheology control agents, leveling agents (such as, but not limited to, surfactants),
free radical scavengers, and adhesion promoters (such as hexanediol diacrylate and
coupling agents).
[0168] Examples of static dyes (i.e., tints or dyes that are not photochromic) that can
be present in the photochromic coating composition and the resulting photochromic
coating layer include, but are not limited to, art-recognized static organic dyes
that are capable of imparting a desired color or other optical property to the photochromic
coating layer. Examples of static dyes that can be present in the photochromic coating
composition and photochromic coating layer include, but are not limited to, azo dyes,
anthraquinone dyes, xanthene dyes, azime dyes, iodine, iodide salts, polyazo dyes,
stilbene dyes, pyrazolone dyes, triphenylmethane dyes, quinoline dyes, oxazine dyes,
thiazine dyes, polyene dyes, and mixtures and/or combinations thereof. Examples of
anthraquinone dyes from which the fixed dye can be selected, with some embodiments,
include but are not limited to, 1,4-dihydroxy-9,10-antracenedione (
CAS registry No. 81-64-1), 1,4-bis(4-methylphenyl)amino-9,10-anthracendione (
CAS registry No. 128-80-3), 1,4-bis((2-bromo-4,6-dimethylphenyl)amino)-9,10-anthracenedione (
CAS registry No. 18038-98-8), and mixtures thereof.
[0169] With some embodiments, the photochromic coating layer is formed from a photochromic
coating composition that includes one or more radically polymerizable monomers. Classes
and examples of radically polymerizable monomers that can be included in the photochromic
coating composition, with some embodiments, include, but are not limited to, those
as described previously herein with regard to the lens molding composition. Photochromic
coating compositions that include one or more radically polymerizable monomers can
further include, with some embodiments, one or more solvents as described previously
herein, one or more additives as described herein, and one or more initiators as described
previously and further herein.
[0170] Non-limiting examples of photoinitiators that can be present in the photochromic
coating composition, include, but are not limited to, cleavage-type photoinitiators
and abstraction-type photoinitiators. Non-limiting examples of cleavage-type photoinitiators
include acetophenones, α-aminoalkylphenones, benzoin ethers, benzoyl oximes, acylphosphine
oxides and bisacylphosphine oxides or mixtures of such initiators. A commercial example
of such a photoinitiator is DAROCURE® 4265, which is available from Ciba Chemicals,
Inc. Non-limiting examples of abstraction-type photoinitiators include benzophenone,
Michler's ketone, thioxanthone, anthraquinone, camphorquinone, fluorone, ketocoumarin
or mixtures of such initiators.
[0171] Another non-limiting example of a photoinitiator that can be present in the photochromic
coating composition, is a visible light photoinitiator. Examples of suitable visible
light photoinitiators include but are not limited to, benzil, benzoin, benzoin methyl
ether, benzoin isobutyl ether benzophenol, acetophenone, benzophenone, 4,4'-dichlorobenzophenone,
4,4'-bis(N,N'-dimethylamino)benzophenone, diethoxyacetophenone, fluorones, e.g., the
H-Nu series of initiators available from Spectra Group Limited, 2-hydroxy-2-methyl-1-phenylpropan-1-one,
1-hydroxycyclohexyl phenyl ketone, 2-isopropylthixantone, alpha-aminoalkylphenone,
e.g., 2-benzyl-2-dimethylamino-1-(4-morpholinophenyl)-1-butanone, acylphosphine oxides,
e.g., 2,6-dimethylbenzoyldlphenyl phosphine oxide, 2,4,6-trimethylbenzoyldiphenylphosphine
oxide, 2,6-dichlorobenzoyldiphenylphosphine oxide, and 2,6-dimethoxybenzoyldiphenylphosphine
oxide, bisacylphosphine oxides, e.g., bis(2,6-dimethyoxybenzoyl)-2,4,4-trimethylepentylphosphine
oxide, bis(2,6-dimethylbenzoyl)-2,4,4-trimethylpentylphosphine oxide, bis (2,4,6-trimethylbenzoyl)-2,4,4-trimethylpentylphosphine
oxide, and bis(2,6-dichlorobenzoyl)-2,4,4-trimethylpentylphosphine oxide, phenyl-4-octyloxyphenyliodonium
hexafluoroantimonate, dodecyldiphenyliodonium hexafluoroantimonate, (4-(2-tetradecanol)oxyphenyl)iodonium
hexafluoroantimonate and mixtures thereof. Further examples of photoinitiators are
set forth at column 12, line 11 to column 13, line 21 of
U.S. Patent 6,602,603.
[0172] Examples of thermal initiators include, but are not limited to, organic peroxy compounds
and azobis(organonitrile) compounds. Examples of organic peroxy compounds that are
useful as thermal initiators include, but are not limited to, peroxymonocarbonate
esters, such as tertiarybutylperoxy isopropyl carbonate; peroxydicarbonate esters,
such as di(2-ethylhexyl) peroxydicarbonate, di(secondary butyl) peroxydicarbonate
and diisopropylperoxydicarbonate; diacyperoxides, such as 2,4-dichlorobenzoyl peroxide,
isobutyryl peroxide, decanoyl peroxide, lauroyl peroxide, propionyl peroxide, acetyl
peroxide, benzoyl peroxide and p-chlorobenzoyl peroxide; peroxyesters such as t-butylperoxy
pivalate, t-butylperoxy octylate and t-butylperoxyisobutyrate; methylethylketone peroxide,
and acetylcyclohexane sulfonyl peroxide. In one non-limiting embodiment the thermal
initiators used are those that do not discolor the resulting polymerizate. Examples
of azobis(organonitrile) compounds that can be used as thermal initiators include,
but are not limited to, azobis(isobutyronitrile), azobis(2,4-dimethylvaleronitrile)
or a mixture thereof.
[0173] Examples of polymerization inhibitors include, but are not limited to: nitrobenzene,
1,3,5,-trinitrobenzene, p-benzoquinone, chloranil, DPPH, FeCl
3, CuCl
2, oxygen, sulfur, aniline, phenol, p-dihydroxybenzene, 1,2,3-trihydroxybenzene, and
2,4,6-trimethylphenol.
[0174] Additional additives that can be present in the photochromic coating composition
include hydrolysates of coupling agents, and mixtures thereof. As used herein "coupling
agent" means a material having at least one group capable of reacting, binding and/or
associating with a group on at least one surface. With some embodiments, a coupling
agent can serve as a molecular bridge at the interface of at least two surfaces that
can be similar or dissimilar surfaces. Coupling agents, with further embodiments,
can be monomers, oligomers, pre-polymers and/or polymers. Such materials include,
but are not limited to, organo-metallics such as silanes, titanates, zirconates, aluminates,
zirconium aluminates, hydrolysates thereof and mixtures thereof. As used herein the
phrase "at least partial hydrolysates of coupling agents" means that at least some
to all of the hydrolyzable groups on the coupling agent are hydrolyzed.
[0175] Additional additives that can be present in the photochromic coating composition
include other adhesion enhancing ingredients. For example, although not limiting herein,
the photochromic coating composition can further include an adhesion-enhancing amount
of an epoxy-containing material. Adhesion-enhancing amounts of an epoxy-containing
materials when included in the photochromic coating composition, can improve the adhesion
of a subsequently applied coating or layer thereto. A class of an epoxy (or oxirane)
functional adhesion promoters that can be included in photochromic coating composition
include, but are not limited to, oxirane-functional-alkyl-trialkoxysilanes, such as
gammaglycidoxypropyltrimethoxysilane, and beta-(3,4-epoxycyclohexyl)ethyltrimethoxysilane.
[0176] In accordance with some embodiments, the photochromic coating composition includes
an aminoplast crosslinker (such as, but not limited to, a melamine crosslinker) and
one or more reactive components having functional groups that are reactive with the
aminoplast crosslinker, such as, but not limited to, hydroxyl, carbamate, and/or urea,
and is referred to as an aminoplast based photochromic coating composition. Non-limiting
examples of aminoplast based coating compositions from which the photochromic coating
compositions of the present method can be selected include, but are not limited to,
those described in, for example,
US 6,432,544 B1 and
US 6,506,488.
[0177] With some embodiments, the photochromic coating composition is a polysilane (or polysiloxane)
photochromic coating composition that includes hydrolysable silane monomers, such
as, but not limited to, tetraalkoxy silane (such as tetraethoxy silane and/or tetramethoxy
silane), and/or alkyl alkoxy silanes in which the alkyl group optionally includes
a functional group, such as oxirane, vinyl, amine, and/or (meth)acryloyl. Non-limiting
examples of polysilane based coating compositions from which the photochromic coating
compositions of the present method can be selected include, but are not limited to,
those described in, for example,
US 4,556,605,
US 6,624,237 B2, and
US 7,157,518 B2.
[0178] In accordance with some further embodiments, the photochromic coating composition
includes one or more components (such as, but not limited to oligomers and/or polymers)
having two or more carboxylic acid anhydride groups and one or more reactive components
each independently having two or more groups that are reactive with carboxylic acid
anhydride groups, such as hydroxyls, which can be referred to as carboxylic acid anhydride
based coating compositions. Non-limiting examples of carboxylic acid anhydride based
coating compositions from which the photochromic coating compositions of the present
method can be selected include, but are not limited to, those described in, for example,
US 4,798,745,
US 4,798,746, and
US 5,239,012.
[0179] With some additional embodiments, the photochromic coating composition includes one
or more components (such as, but not limited to oligomers and/or polymers) that include
residues of alkoxyacrylamide monomers, such as but not limited to N-alkoxymethyl(meth)acrylamide
monomers, which can be referred to as alkoxyacrylamide based coating compositions.
Non-limiting examples of alkoxyacrylamide based coating compositions from which the
photochromic coating compositions of the present method can be selected include, but
are not limited to, those described in, for example,
US 6,060,001 and
5,618,586.
[0180] With some further additional embodiments, the photochromic coating composition includes
one or more components (such as, but not limited to oligomers and/or polymers) having
two or more oxirane groups, and one or more reactive components each independently
having two or more groups that are reactive with oxirane groups, such as hydroxyls,
thiols, carboxylic acids, and amines, which can be referred to as oxirane (or epoxy)
based coating compositions. Non-limiting examples of oxirane based coating compositions
from which the photochromic coating compositions of the present method can be selected
include, but are not limited to, those described in, for example,
US 4,756,973 and
US 6,268,055 B1.
[0181] The method of the present invention further includes, with some embodiments, forming
at least one further layer over at least one of: the front surface of the segmented
multifocal finished lens; the rear surface of the segmented multifocal finished lens;
and the photochromic coating layer. Each further layer is independently selected,
with some embodiments, from primer coating layers, protective coating layers, anti-reflective
coating layers, polarizing layers, and combinations thereof.
[0182] In accordance with some embodiments, at least one of the at least one further layers
is interposed between the rear surface of the segmented multifocal finished lens,
and the photochromic coating layer. With some further embodiments, at least one primer
coating layer and/or at least one protective coating layer is formed and interposed
between the rear surface of the segmented multifocal finished lens, and the photochromic
coating layer. With some additional embodiments, (i) the organic matrix of the segmented
multifocal lens blank (and correspondingly of the finished lens) includes polycarbonate,
and (ii) at least one primer coating layer and/or at least one protective coating
layer is formed and interposed between the rear surface of the segmented multifocal
finished lens, and the photochromic coating layer.
[0183] The optional primer coating layer can include a single layer or multiple layers,
each having the same or a different composition. The optional primer coating layer
typically includes an organic matrix, such as a thermoplastic organic matrix and/or
a crosslinked organic matrix. Additionally or alternatively to an organic matrix,
the optional primer layer can include an inorganic matrix, including, for example,
silane linkages, siloxane linkages and/or titanate linkages. The organic matrix of
the optional primer coating layer, with some embodiments, is as described previously
herein with regard to the photochromic coating layer. With some embodiments, the organic
matrix of the optional primer coating layer includes, for example: acrylate residues
(or monomer units) and/or methacrylate residues; vinyl residues; ether linkages; sulfide
linkages, including monosulfide linkages and/or polysulfide linkages; carboxylic ester
linkages; carbonate linkages (e.g., -O-C(O)-O-) urethane linkages (e.g., -N(H)-C(O)-O-);
carbon-carbon linkages; and/or thiourethane linkages (e.g., - N(H)-C(O)-S-).
[0184] Typically, the optional primer coating layer is formed from a primer coating composition.
The primer coating composition can be a curable primer coating composition, that is
curable by exposure to, for example: ambient temperatures, such as in the case of
two component coating compositions; elevated temperatures (e.g., 80°C to 150°C for
5 to 60 minutes), such as in the case of thermally cured coating compositions; or
actinic radiation, such as in the case of ultraviolet light curable coating compositions.
[0185] The optional primer coating layer can have any suitable thickness. With some embodiments,
the optional primer coating layer has a thickness of from 0.5 microns to 20 microns,
such as from 1 to 10 microns, or from 2 to 8 microns, or from 3 to 5 microns, inclusive
of the recited values.
[0186] The optional protective coating layer is, with some embodiments, selected from an
abrasion-resistant coating, such as a "hard coat." Each protective coating layer can
include a single layer or multiple layers, each having the same or a different composition.
The optional protective coating layer can be selected from abrasion-resistant coatings
including organo silanes, abrasion-resistant coatings including radiation-cured acrylate-based
thin films, abrasion-resistant coatings based on inorganic materials such as silica,
titania and/or zirconia, organic abrasion-resistant coatings of the type that are
ultraviolet light curable, oxygen barrier-coatings, UV-shielding coatings, and combinations
thereof. With some embodiments, the optional protective coating layer is a hard coat
layer that includes a first coating of a radiation-cured acrylate-based thin film
and a second coating including an organo-silane. Non-limiting examples of commercially
available hard coating products include CRYSTALCOAT
® abrasion-resistant coatings, commercially available from SDC Coatings, Inc., and
HI-GARD® coatings, commercially available from PPG Industries, Inc.
[0187] The optional protective coating layer can be selected from art-recognized hard coat
materials, such as organo-silane abrasion-resistant coatings. Organo-silane abrasion-resistant
coatings, often referred to as hard coats or silicone-based hard coatings, are well
known in the art, and are commercially available from various manufacturers, such
as SDC Coatings, Inc. and PPG Industries, Inc. Reference is made to
U.S. Pat. No. 4,756,973 at column 5, lines 1-45; and to
U.S. Pat. No. 5,462,806 at column 1, lines 58 through column 2, line 8, and column 3, line 52 through column
5, line 50, which disclosures describe organo-silane hard coatings Reference is also
made to
U.S. Pat. Nos. 4,731,264,
5,134,191,
5,231,156 and International Patent Publication
WO 94/20581 for disclosures of organo-silane hard coatings. The hard coat layer can be applied
by those coating methods as described previously herein with regard to the primer
layer, such as spin coating.
[0188] Other coatings that can be used to form the optional protective coating layer, include,
but are not limited to, polyfunctional acrylic hard coatings, melamine-based hard
coatings, urethane-based hard coatings, alkyd-based coatings, silica sol-based hard
coatings or other organic or inorganic/organic hybrid hard coatings.
[0189] The optional protective coating layer, with some embodiments, is selected from art-recognized
organo-silane type hard coatings. Organo-silane type hard coatings from which the
optional protective coating layer can be selected include, but are not limited to,
those disclosed at column 24, line 46 through column 28, line 11 of United States
Patent No.
7,465,414 B2.
[0190] Further examples of coating compositions from which the optional protective coating
layer can be prepared, with some embodiments, include but are not limited to: (meth)acrylate
based protective coating compositions, such as described in
US 7,410,691; radiation curable acrylate based protective coating compositions, such as described
in
US 7,452,611 B2; thermally cured protective coating compositions, such as described in
US 7,261,843; maleimide based protective coating compositions, such as described in
US 7,811,480; and dendritic polyester (meth)acrylate based protective coating compositions, such
as described in
US 7,189,456.
[0191] The optional anti-reflective coating layer can be selected from art-recognized anti-reflective
coating layers, and typically includes at least two layers each having a different
refractive index. With some embodiments, the optional anti-reflective coating layer
includes a first layer having a refractive index of from 1.6 to 2.5, or from 1.95
to 2.4, and a second layer having a refractive index of from 1.30 to 1.48, or from
1.38 to 1.48. The optional anti-reflective coating layer includes, with some embodiments,
a plurality of such alternating first and second layers. With some embodiments, the
first layer of the optional anti-reflective coating layer includes at least one of,
TiO
2, Ti
2O
3, Ti
3O
5, Pr
6O
11 + xTiO
2, CeO
2, HfO
2, Ta
2O
5, ZrO
2, and SnO
2. With some embodiments, the second layer of the optional anti-reflective coating
layer includes at least one of, SiO
2, MgF
2, AlF
3, BaF2, Na
5Al
3F
14, Na
3AlF
6, and YF
3. Examples of anti-reflective coating layers from which the optional anti-reflective
coating layer can be selected are described in United States Patent No.
6,175,450 B1 at column 1, line 56 through column 2, line 7; column 2, lines 50-65; and column
5, lines 22-58.
[0192] Each optional polarizing layer can, with some embodiments, be selected from art-recognized
polarizing layers. With some embodiments, each optional polarizing layer is a conventional
linearly polarizing layer formed from one or more layers of unilaterally stretched
polymer films, such as unilaterally stretched polyvinyl alcohol films, optionally
containing a dichroic material.
[0193] The present invention is more particularly described in the following examples, which
are intended to be illustrative only, since numerous modifications and variations
therein will be apparent to those skilled in the art. Unless otherwise specified,
all parts and all percentages are by weight.
EXAMPLES
[0194] Parts A through E of the present examples are summarized as follows. In Part A, the
preparation of photochromic compounds, which are used in the photochromic coating
formulations of Part B, is described. In Part B, the preparation and compositions
of photochromic coating formulations C-1 and C-2 are described. In Part C, the preparation
of the surfaces of lenses to which the photochromic coating formulations are applied,
is described. In Part D, application of the photochromic coating formulations to the
lenses and curing thereof is described. In Part E, testing of the coated lenses is
described, and the results of such testing tabulated and discussed.
PART A
Photochromic compounds
[0195] The preparation of photochromic compounds PC-1 through PC-8 is provided as follows.
PC-1
[0196] 3,3-di(4-methoxyphenyl)-13,13-dimethyl-3H-13H-indeno[2',3':3,4]naphtho[1,2-b]pyran
was prepared according to the procedure of Example 4 in
US 7,527,754, but replacing 1-(4-fluorophenyl)-1-(4-morpholinophenyl)-2-propyn-1-ol with an equimolar
amount of 1,1-bis(4-methoxyphenyl)-2-propyn-1-ol (the product of example 1 step 1
in
U.S. patent 5,458,814).
PC-2
[0197] 3-(4-piperidinophenyl)-3-phenyl-6,11-difluoro-13,13-dimethyl-3H-13H-indeno[2',3':3,4]naphtho[1,2-b]pyran
was prepared according to the procedure of Example 4 in
US 7,556,751.
PC-3
[0198] 3-(4-fluorophenyl)-3-(4-morpholinophenyl)-13,13-dimethyl-3H-13H-indeno[2',3':3,4]naphtho[1,2-b]pyran
was prepared according to the procedure of Example 4 in
US 7,527,754,
PC-4
[0199] 3-(4-butoxyphenyl)-3-(4-methoxyphenyl)-6,7-dimethoxy-11-trifluoromethyl-13,13-dimethyl-3H-13H-indeno[2',3':3,4]naphtho[1,2-b]pyran
was prepared according to the procedure of Example 1 in
US 8,748,634,
but replacing 1,1-bis(4-methoxyphenyl)-2-propyn-1-ol with an equimolar amount of 1-(4-butoxyphenyl)-1-(4-methoxyphenyl)-2-propyn-1-ol.
PC-5
Step 1.
[0200] 2,3-dimethoxy-7,7-dimethyl-9-cyano-7H-benzo[C]fluoren-5-ol (3.0 g, the product of
Example 1, Step 1 of
U.S. Pub. No. 2006/0228557 A1, and 3,4-dihydro-2H-pyran (1.5 grams) were placed in a reaction flask and 100 mL
of dichloromethane was added. The reaction mixture was stirred at room temperatures
for 4 hours. The mixture was filtered through a silica gel plug and the organic filtrate
was removed by rotary evaporation to give 3.2 grams of grey solid. An NMR spectrum
showed the product to have a structure consistent with 2,3-dimethoxy-5-((tetrahydro-2H-pyran-2-yl)oxy)-7,7-dimethyl-7H-9-cyano-benzo[C]-fluorene.
Step 2
[0201] The product from Step 1 (3.0 grams), potassium hydroxide (1.18 grams) and iodohexane
(4.4 grams) were placed in a reaction flask and 150 mL of t-butyl alcohol was added.
The reaction mixture was heated at reflux temperatures for 4 hours and cooled to room
temperature. The mixture was poured into 200 mL of water and extracted with ethyl
acetate. The organic solvent was removed by rotary evaporation to give 3.4 grams of
grey solid. An NMR spectrum showed the product to have a structure consistent with
N-hexyl-2,3-dimethoxy-5-((tetrahydro-2H-pyran-2-yl)oxy)-7,7-dimethyl-7H-benzo[C]-fluorene-9-carboxamide.
Step 3.
[0202] The product from Step 2 (3.0 grams) was placed in a reaction flask and 100 mL of
methanol was added. The reaction mixture was heated at reflux temperature and a few
drops of concentrated HCl were added. The mixture was poured into 200 mL of water
and extracted with ethyl acetate. The organic solvent was removed by rotary evaporation
to give 2.5 grams of white solid. An NMR spectrum showed the product to have a structure
consistent with 2,3-dimethoxy-5-hydroxy-7,7-dimethyl-7H-9-cyano-benzo[C]-fluorene.
Step 4.
[0203] The product from Step 3 (2 grams), 1,1-bis(4-methoxyphenyl)-2-propyn-1-ol (2.0 grams),
dodecylbenzene sulfonic acid (0.5 grams) and chloroform (preserved with pentene, 250
mL) were combined in a reaction flask and stirred at room temperature for 5 hours.
The reaction mixture was washed with 50 % saturated aqueous sodium bicarbonate (200
mL) and the organic layer was dried over anhydrous sodium sulfate. The solvent was
removed by rotary evaporation. Hot methanol was added to the resulting residue and
then the mixture cooled to room temperature. The precipitate obtained was collected
by vacuum filtration and washed with cold methanol yielding 2.7 grams of N-hexyl-3,3-di(4-methoxyphenyl)-6,7-dimethoxy-13-dimethyl-3H,13H-indeno[2',3':3,4]naphtho[1,2-b]pyran-11-carboxamide.
PC-6
[0204] 3-(4-methoxyphenyl)-3-(4-morpholinophenyl)-6-methoxy-7-piperidino-11-phenyl-13,13-dimethyl-3H-13H-indeno[2',3':3,4]naphtho[1,2-b]pyran
was prepared according to the procedure of Comparative Example CE-6 in
US 8,147,725.
PC-7
[0205] 3,3-di(4-methoxyphenyl)-6-methoxy-7-piperidino-11-phenyl-13,13-dimethyl-3H-13H-indeno[2',3':3,4]naphtho[1,2-b]pyran
was prepared according to the procedure of Comparative Example CE-4 in
US 8,147,725.
PC-8
[0206] 3-(4-fluorophenyl)-3-(4-morpholinophenyl)-6,11-dimethoxy-13,13-dimethyl-3H-13H-indeno[2',3':3,4]naphtho[1,2-b]pyran
was prepared according to the procedure of Example 4 in
US 7,527,754, which procedure is incorporated herein by reference, but replacing 7,7-dimethyl-7H-benzo[C]fluorene-5-ol
with an equimolar amount of 3,9-dimethoxy-7,7-dimethyl-7H-benzo[C]fluorene-5-ol (the
product of Example 14, step 1 in
U.S. Pub. No. 2006/0228557 A1).
PART B
Photochromic Coating Formulations
[0207]
Table 1 - Photochromic coating formulations
| Material |
Coating C-1 (parts by weight) |
Coating C-2 (parts by weight) |
| Charge 1 |
| N-methyl-2-pyrrolidone |
21.2133 |
26.3260 |
| PC-1 |
0.1590 |
- |
| PC-2 |
0.1590 |
- |
| PC-3 |
1.2718 |
- |
| PC-4 |
0.9539 |
- |
| PC-5 |
0.6359 |
- |
| PC-6 |
- |
1.0978 |
| PC-7 |
- |
1.0556 |
| PC-8 |
- |
1.0493 |
| TINUVIN® 292(1) |
- |
0.7943 |
| IRGANOX® 245(2) |
1.0599 |
- |
| TINUVIN® 144(3) |
1.0599 |
- |
| Charge 2 |
| SILQUEST® A-187(4) |
2.6505 |
1.8759 |
| K-KAT® 348(5) |
0.5307 |
0.4737 |
| BYK® 333(6) |
0.0400 |
0.0669 |
| Acrylic polyol(7) |
16.2913 |
- |
| PC1122(8) |
15.9859 |
30.3268 |
| TRIXENE® BI-7960(9) |
28.1656 |
18.7336 |
| DESMODUR® PL340(10) |
9.8234 |
6.5490 |
| N-methyl-2-pyrrolidone |
- |
11.6512 |
(1) A hindered amine light stabilizer, commercially available from BASF.
(2) An antioxidant commercially available from BASF.
(3) A hindered amine light stabilizer commercially available from BASF.
(4) A gamma-glycidoxypropyl trimethoxysilane, available from Osi Specialties of Paris,
France
(5) A urethane catalyst available from King Industries Inc.
(6) Apolyether modified dimethylpolysiloxane compolymer, available from BYK-Chemie
(7) A poly(meth)acrylic polyol produced by following the procedure of Composition D of
Example 1 in U.S. Patent 6,187,444, which procedure is incorporated herein by reference, except that in Charge 2, the
styrene was replaced with methyl methacrylate and 0.5 % by weight triphenyl phosphite
was added, based on the total monomer weight.
(8) A polycarbonate diol, available from Stahl.
(9) A blocked hexamethylene diisocyanate available from Baxenden Chemical Co.
(10) A blocked aliphatic polyisocyanate, available from Bayer Material Science. |
[0208] The ingredients of Charge 1 were added to a suitable vessel with stirring, and heated
to 60°C for approximately 30 minutes to dissolve the solids. The ingredients of Charge
2 were added to a separate vessel and mixed thoroughly. Charge 2 was added to Charge
1, and the resulting mixture was placed in a container which was then placed on a
WHEATON® 348923-A Benchtop Roller, available from Wheaton Industries, Inc., for a
minimum of 6 hours prior to use.
PART C
Preparation of lens surface
[0209] In the following Examples, back side (BS) refers to the concave surface, while front
side (FS) refers to the convex surface of a lens substrate.
[0210] To demonstrate the attenuating effect of polycarbonate lenses on the activation of
photochromic coatings on the back side, 76 mm diameter PDQ® coated polycarbonate piano
lenses (available from Gentex Optics, Inc.) with a 6.25 base curve were used as substrates
in Examples 1 and 1A, as well as in Comparative Examples CE-1 and CE-1A. The piano
lenses were used as supplied without further cleaning. The smooth geometry of piano
lenses allowed for facile measurement of performance by the method described below
in Part E.
[0211] A segmented bifocal polycarbonate lens substrate of 6.75 base curve with +2.00 straight
top 28 mm add was used in Example 2. The lens of Example 2 was ground to a prescription
power of -4.00. A segmented bifocal polycarbonate substrate of 4.75 base curve with
+2.00 straight top 28 mm add was used in Example 3. The lens of Example 3 was ground
to a prescription power of +4.00. The ground lenses of Examples 2 and 3 were washed
with mild soap and water, rinsed with deionized water, and finally rinsed with isopropyl
alcohol prior to plasma treatment described below.
[0212] Prior to the application of each coating layer, the substrate lenses were subjected
to oxygen plasma at a flow rate of 100 milliliters (mL) per minute of oxygen at 120
watts of power for three minutes. The treatment was applied to the surface which was
to be subsequently coated for each Example.
[0213] Following oxygen plasma treatment on the back side, the lenses of Examples 2 and
3 were first coated with HI-GARD® 1080 Lens Coating (commercially available from PPG
Industries, Inc.) by spin coating. For each of Examples 2 and 3, HI-GARD 1080 was
applied to the back side surface and the lens was rotated at 1067 rpm for 8 seconds.
The coated lenses were subsequently baked for 1 hour at 120°C. Once cooled, the coated
lenses were subject to oxygen plasma under the conditions described above prior to
the application of the photochromic coating layer. Examples 1, 1A, CE-1 and CE-1A
did not receive this first coating layer.
PART D
Application of photochromic coatings
[0214] The lenses prepared in Part C were coated with the photochromic coating solutions
C-1 or C-2 via a spin coating process. Approximately 1.5 mL of the respective coating
solution was dispensed onto the indicated surface of the lens, which was subsequently
rotated for 8 seconds at the speeds according to Table 2. The spin speed listed in
Table 2 were determined so as to achieve a target coating thickness of approximately
20 microns. The coated lenses were stored in a forced air oven at 40°C for up to 30
minutes, followed by a 1 hour cure cycle in a forced air oven at 120°C. After removal
from the oven and cooling for a minimum of 15 minutes, the lenses were again treated
with oxygen plasma as above. Each of the lenses were then spin coated with HI-GARD
1080 at a spin speed of 1067 rpm for 8 seconds. The lenses were then cured for 3 hours
at 120°C. Attempts to apply photochromic coatings to the front surface of the bifocal
lens substrates resulted in visually unacceptable, uneven coating thicknesses in the
area of the bifocal edge, and thus were not pursued further.
Table 2 - Photochromic coating parameters
| Example |
Photochromic Coating |
Lens surface coated |
Spin speed (rpm) |
| CE-1 |
C-1 |
BS |
644 |
| CE-1A |
C-1 |
FS |
765 |
| 1 |
C-2 |
BS |
644 |
| 1A |
C-2 |
FS |
644 |
| 2 |
C-2 |
BS |
916 |
| 3 |
C-2 |
BS |
916 |
PART E
Performance Testing
[0215] Lens Examples with coatings on the back side (BS) were tested for photochromic response
(e.g., the change in optical density) under conditions simulating outdoor exposure
with activation Through the Lens (TL). Lens Examples with coatings on the front side
(FS) were tested for photochromic response under conditions simulating outdoor exposure
in the Outdoor Simulation Test (OS).
[0216] The photochromic samples prepared as described in Part D were tested for photochromic
response in the Outdoor Simulation (OS) Test and the Through the Lens (TL) Test as
described herein on an Advance Bench for Measuring Photochromics (A-BMP) optical bench
custom made by PPG Industries, Inc. The TL Test was used to activate a photochromic
lens with the activating solar light passing through the lens to reach the backside
coating. The irradiance intensity at the front side of all coated lenses for both
the OS test and the TL test was 6.7 Watts/m
2 (UVA) integrated between 315 and 380 nm and 50 Klux. The TL was tested with the photochromic
coated side (back side) facing away from the activation source. The OS was tested
with the photochromic coated side (front side) facing toward the activation source.
[0217] Prior to testing on the optical bench, the photochromic lenses were conditioned by
activating and fading as described hereinafter. The lenses were first exposed to 365
nanometer ultraviolet light for about 10 minutes at a distance of about 14 centimeters
to activate the photochromic compounds. The UVA (315 to 380 nm) irradiance at the
sample was measured with a Licor Model Li-1800 spectroradiometer and found to be 22.2
watts per square meter. The activated samples were then placed under a 500 watt, high
intensity halogen lamp for about 10 minutes at a distance of about 36 centimeters
to bleach or inactivate the photochromic compounds. The illuminance at the sample
was measured with the Licor spectroradiometer and found to be 21.4 Klux. The lenses
were then kept covered for at least 1 hour prior to testing on an optical bench.
[0218] The A-BMP optical bench was fitted with two 150 watt Xenon arc lamps positioned 90°
apart (one lamp to provide the amount of UV/VIS light and one to provide the additional
contribution of visible light). The collimated output beams from the xenon arc lamps
were combined and directed toward the sample cell through a 50/50 beam splitter. Each
lamp was filtered and shuttered individually and also shuttered after blending, prior
to entering the sample cell. The light path from Lamp 1 was directed through a 3 mm
Schott KG-2 band-pass filter and appropriate neutral density filters that contributed
to the required UV and partial VIS light irradiance level. The light path from the
Lamp 2 was directed through a 3 mm Schott KG-2 band-pass filter, a 400 nm cutoff filter
and neutral density filters in order to provide supplemental VIS light illuminance.
The samples were controlled at a temperature of 23°C using an FTS™ Systems AirJet™
XE maintained at 3.5cfm pressure flow through sample chamber. Proprietary software
was used on the A-BMP to control timing, irradiance, air cell and sample temperature,
shuttering, filter selection and response measurement. A Zeiss spectrophotometer,
Model MCS 601, with fiber optic cables for light delivery through the sample was used
for response and color measurement.
[0219] Response measurements, in terms of change in optical density (ΔOD) from the unactivated
state to the activated or darkened state were determined by establishing the initial
unactivated transmittance, opening the shutter from the Xenon lamp(s) and measuring
the transmittance during activation of the sample at selected intervals of time. The
term "ΔOD" and equivalent recitations, such as "delta OD," means change in optical
density (OD) and is determined according to the formula:

[0220] In the above formula, %Tb is the percent photopic transmittance in the bleached state
(or non-colored state), %Ta is the percent photopic transmittance in the activated
state (or colored state) and the logarithm is to the base 10.
[0221] Related Examples were compared to one another to obtain retained optical density,
calculated by using the following formula:
Table 3 - Photochromic performance
| Example |
Coating Example |
Lens surface coated |
OS or TL Tested |
Activated OD@23°C |
%ΔOD Retained |
| CE-1 |
C-1 |
BS |
TL |
0.61 |
70 |
| CE-1A |
C-1 |
FS |
OS |
0.87 |
- |
| 1 |
C-2 |
BS |
TL |
1.23 |
96 |
| 1A |
C-2 |
FS |
OS |
1.28 |
- |
| 2 |
C-2 |
BS |
TL |
*Photochromic with no visible irregularities |
|
| 3 |
C-2 |
BS |
TL |
*Photochromic with no visible irregularities |
|
| *Due to the irregular geometry of the surface of the bifocal lens, accurate measurements
could not be made. |
[0222] Comparison of OS and TL results in Table 3 demonstrates the attenuation of incident
light when a coating is irradiated through the lens. Examples 1 and 1A demonstrate
the improved performance of a dye package that comprises dyes with pi-conjugation
extending groups as compared with the absence of such dyes in Comparative Examples
CE-1 and CE-1A.
[0223] The present invention has been described with reference to specific details of particular
embodiments thereof. It is not intended that such details be regarded as limitations
upon the scope of the invention except insofar as and to the extent that they are
included in the accompanying claims.